<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29304370</article-id>
<article-id pub-id-type="pmc">5777382</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(17)30454-8</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2017.11.002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Expanding Landscape of Alternative Splicing Variation in Human Populations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Eddie</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Zhicheng</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zijun</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Lan</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xing</surname>
<given-names>Yi</given-names>
</name>
<email>yxing@ucla.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Microbiology, Immunology, &amp; Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA</aff>
<aff id="aff2"><label>2</label>Bioinformatics Interdepartmental Graduate Program, University of California, Los Angeles, Los Angeles, CA 90095, USA</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>yxing@ucla.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>04</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>102</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>26</lpage>
<permissions>
<copyright-statement>© 2017 The Authors</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<p>Alternative splicing is a tightly regulated biological process by which the number of gene products for any given gene can be greatly expanded. Genomic variants in splicing regulatory sequences can disrupt splicing and cause disease. Recent developments in sequencing technologies and computational biology have allowed researchers to investigate alternative splicing at an unprecedented scale and resolution. Population-scale transcriptome studies have revealed many naturally occurring genetic variants that modulate alternative splicing and consequently influence phenotypic variability and disease susceptibility in human populations. Innovations in experimental and computational tools such as massively parallel reporter assays and deep learning have enabled the rapid screening of genomic variants for their causal impacts on splicing. In this review, we describe technological advances that have greatly increased the speed and scale at which discoveries are made about the genetic variation of alternative splicing. We summarize major findings from population transcriptomic studies of alternative splicing and discuss the implications of these findings for human genetics and medicine.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>Main Text</title>
<sec id="sec1.1">
<title>Introduction</title>
<p id="p0010">Pre-mRNA splicing is a conserved biological process in which introns within nascent RNA molecules are removed and exons are ligated to form mature mRNA products.<xref ref-type="bibr" rid="bib1"><sup>1</sup></xref> Through alternative choices of exons and splice sites during splicing—a process known as alternative splicing—a single gene can produce multiple mRNA isoforms that dramatically diversify the transcriptome and the proteome.<xref ref-type="bibr" rid="bib2"><sup>2</sup></xref> Although the human genome has only approximately 20,000 protein-coding genes,<xref ref-type="bibr" rid="bib3"><sup>3</sup></xref> the unique mRNA isoforms generated from each gene can be more than ten times that number.<xref ref-type="bibr" rid="bib4"><sup>4</sup></xref> Nearly all multi-exon human genes are alternatively spliced.<xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref> The basic patterns of alternative splicing include exon skipping, alternative 5′ and 3′ splice sites, mutually exclusive exons, intron retention, and alternative splicing coupled with alternative first or last exons (<xref ref-type="fig" rid="fig1">Figure 1</xref>A). Beyond these basic patterns involving binary choices of exons or splice sites during splicing, many complex alternative splicing patterns exist in the transcriptome<xref ref-type="bibr" rid="bib7"><sup>7</sup></xref> (see <xref ref-type="fig" rid="fig1">Figure 1</xref>B for examples). In extreme cases, the combinatorial choices of multiple alternatively spliced regions can generate tens of thousands of mRNA isoforms from a single gene.<xref ref-type="bibr" rid="bib8"><sup>8</sup></xref> The resulting mRNA isoforms can have distinct regulatory properties in the cell, such as localization, stability, and translational efficiency, and can be translated into stable protein isoforms with divergent structures and functions.<xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib10">10</xref> Therefore, alternative splicing provides a powerful mechanism for expanding the regulatory and functional repertoire of eukaryotic organisms.<fig id="fig1"><label>Figure 1</label><caption><p>A Primer on Alternative Splicing</p><p>(A and B) Basic (A) and complex (B) patterns of alternative splicing. Dark-blue boxes represent constitutively spliced exons. Red, light-blue, and green boxes represent alternatively spliced exons.</p><p>(C) Alternative splicing is regulated by an extensive protein-RNA interaction network involving <italic>cis</italic> elements within the pre-mRNA and <italic>trans</italic>-acting factors that bind to these <italic>cis</italic> elements. The most essential splicing signals within the pre-mRNA are the 5′ splice site (5′SS), 3′ splice site (3′SS), branch site (A), and polypyrimidine tract (Y(n)). The 5′ and 3′ splice sites have highly conserved GU and AG dinucleotides as the first and last two nucleotides of the intron, respectively. The U1 snRNP complex recognizes the 5′ splice site, and the U2 snRNP complex recognizes the branch site. The U2AF proteins recognize the 3′ splice site and polypyrimidine tract. Exonic splicing enhancers (ESEs), exonic splicing silencers (ESSs), intronic splicing enhancers (ISEs), and intronic splicing silencers (ISSs) are pre-mRNA <italic>cis</italic> regulatory motifs that recruit various RNA-binding proteins (e.g., SR and hnRNP proteins) to regulate alternative splicing.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<p id="p0015">Alternative splicing is regulated in a cell-type- and developmental-stage-specific manner.<xref ref-type="bibr" rid="bib11"><sup>11</sup></xref> This regulation is orchestrated through an extensive protein-RNA interaction network involving <italic>cis</italic> elements within the pre-mRNA and <italic>trans</italic>-acting factors that bind to these <italic>cis</italic> elements<xref ref-type="bibr" rid="bib12"><sup>12</sup></xref> (<xref ref-type="fig" rid="fig1">Figure 1</xref>C). The most conserved <italic>cis</italic> splicing elements include the 5′ and 3′ splice sites that define the boundary of an intron with its upstream and downstream exon, respectively, as well as the branch site and polypyrimidine tract upstream of the 3′ splice site. These elements are recognized by the core splicing machinery (the spliceosome) and play an essential role in defining exon and intron identity.<xref ref-type="bibr" rid="bib12"><sup>12</sup></xref> In addition to these core elements, auxiliary <italic>cis</italic> elements in exons or flanking introns can act as splicing enhancer or silencer elements to promote or repress exon splicing via their interactions with <italic>trans</italic>-acting splicing regulators, in particular RNA-binding proteins (RBPs).<xref ref-type="bibr" rid="bib13"><sup>13</sup></xref> For example, cell-type-specific splicing regulators, such as ESRP, CELF, MBNL, RBFOX, and PTB family members, control the alternative splicing profiles and cell identities of epithelial, muscle, and neuronal cells by interacting with their cognate <italic>cis</italic> elements within the pre-mRNA to produce cell-type-specific isoforms.<xref ref-type="bibr" rid="bib11"><sup>11</sup></xref></p>
<p id="p0020">Alternative splicing is frequently affected by human genetic variants and disease mutations. A large fraction of human disease mutations disrupt splice site signals or splicing enhancer or silencer elements within the pre-mRNA, leading to the production of aberrant mRNA and protein products.<xref ref-type="bibr" rid="bib14"><sup>14</sup></xref> It has been estimated that such <italic>cis</italic> splicing mutations constitute 15%–60% of human disease mutations.<xref ref-type="bibr" rid="bib15"><sup>15</sup></xref> Additionally, mutations disrupting <italic>trans</italic>-acting splicing regulators cause a wide spectrum of diseases by globally compromising the splicing of many downstream target genes.<xref ref-type="bibr" rid="bib16"><sup>16</sup></xref> Through decades of genetic and medical research, the role of aberrant splicing as a primary cause of Mendelian diseases has been firmly established and extensively reviewed.<xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib17">17</xref> However, until recently, much less was known and appreciated about the extent of naturally occurring alternative splicing variation among human individuals and how alternative splicing affects phenotypic variability and disease susceptibility in human populations.</p>
<p id="p0025">Recent developments in genomic technologies and computational tools have enabled transcriptome-wide studies of alternative splicing at an unprecedented scale and resolution.<xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref> New data depict an expanding landscape of alternative splicing variation across human tissues and populations. Here, we describe technological advances that have markedly increased the speed and scale at which discoveries are made about the genetic variation of alternative splicing. We review population-scale transcriptome studies that have revealed alternative splicing to be a primary causal mechanism underlying genome-wide association study (GWAS) signals of complex traits and diseases. We highlight innovative experimental and computational approaches that enable the rapid discovery and characterization of genomic variants that alter splicing. Finally, we discuss the clinical applications of these findings as well as their implications for future genetic and medical research.</p>
</sec>
<sec id="sec1.2">
<title>Technologies for High-Throughput Analysis of Alternative Splicing</title>
<p id="p0030">The conventional molecular biology approach to the quantification of alternative splicing is reverse transcription polymerase chain reaction (RT-PCR).<xref ref-type="bibr" rid="bib18"><sup>18</sup></xref> In the late 1990s, sequencing of expressed sequence tags (ESTs), which are fragments of full-length mRNAs, revealed widespread alternative splicing in eukaryotic organisms.<xref ref-type="bibr" rid="bib19"><sup>19</sup></xref> The development of splicing-sensitive microarrays in the mid-2000s allowed researchers to examine global splicing regulatory programs across tissues, cellular states, and species.<xref ref-type="bibr" rid="bib20"><sup>20</sup></xref> Notably, all three types of technologies have been used to discover the association between genotypes and alternative splicing patterns in human populations.<xref ref-type="bibr" rid="bib21"><sup>21</sup></xref> However, these technologies have low throughput (RT-PCR and ESTs), have high noise (ESTs and splicing microarray), or are limited to known splicing events (RT-PCR and splicing microarray).<xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref></p>
<p id="p0035">Powered by high-throughput second-generation DNA sequencers, the advent of RNA sequencing (RNA-seq) in the late 2000s transformed many aspects of biomedical research, including studies of transcriptome complexity and alternative splicing.<xref ref-type="bibr" rid="bib22"><sup>22</sup></xref> Because of their massively parallel nature, state-of-the-art high-throughput sequencers are now able to generate billions of short sequence reads in a single run.<xref ref-type="bibr" rid="bib23"><sup>23</sup></xref> Sequencing mRNAs with these sequencers allows the discovery of novel genes and mRNA isoforms, the estimation of gene expression levels, and the quantitation of alternative splicing events.<xref ref-type="bibr" rid="bib22"><sup>22</sup></xref> Three landmark papers in 2008 demonstrated the use of RNA-seq for characterizing alternative splicing in mammalian tissues.<xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref>, <xref ref-type="bibr" rid="bib24">24</xref> Since then, RNA-seq has rapidly eclipsed microarray as the standard approach for transcriptome profiling. Currently, RNA-seq data for over 70,000 human samples have been deposited into public repositories,<xref ref-type="bibr" rid="bib25"><sup>25</sup></xref> and the number continues to rise at a rapid pace.</p>
<p id="p0040">Although typical RNA-seq experiments analyze polyadenylated (polyA<sup>+</sup>) mRNAs from whole cells or bulk tissue, the RNA-seq workflow is versatile enough to allow diverse types of applications that can obtain transcriptome information at a more fine-grained level.<xref ref-type="bibr" rid="bib26"><sup>26</sup></xref> For example, RNA-seq analysis of non-polyadenylated (polyA<sup>−</sup>) RNAs enables the discovery and quantitation of polyA<sup>−</sup> non-coding RNAs, including circular RNAs created by back-splicing events.<xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib28">28</xref> Isolation and sequencing of RNAs from distinct subcellular fractions have been used for characterizing the subcellular localization of mRNA isoforms as well as co-transcriptional splicing of nascent RNAs on chromatin.<xref ref-type="bibr" rid="bib29">29</xref>, <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref> Single-cell RNA-seq has become an increasingly popular approach to studying the transcriptome, including alternative splicing, at the individual-cell level.<xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref> Finally, although Illumina sequencers generate only short sequence reads, specialized protocols for library preparation can be used for inferring full-length mRNA isoforms with the use of Illumina RNA-seq data. Tilgner et al. developed a “synthetic long read” RNA-seq approach for use with Illumina sequencers.<xref ref-type="bibr" rid="bib34"><sup>34</sup></xref> The principle behind this method is to generate RNA-seq libraries from a given sample separated into many small pools. Each pool contains a small number of RNA molecules (approximately 1,000 or fewer), and the assumption is that for most genes, no more than one molecule per gene is present in each pool. Then, short reads from each pool can be assembled into full-length transcripts by <italic>de novo</italic> sequence assembly algorithms. Using this approach, the authors identified novel mRNA isoforms and determined that certain distant alternatively spliced exons tend to co-occur in full-length mRNA molecules, whereas others tend to be spliced in a mutually exclusive manner. A caveat to this approach is that it is limited by the same issues of <italic>de novo</italic> assembly with short reads, primarily mis-assemblies and repetitive sequences.<xref ref-type="bibr" rid="bib35"><sup>35</sup></xref> Moreover, the assumption of one RNA molecule per gene in each pool might not hold true for highly expressed genes.</p>
<p id="p0045">Ultimately, the interest in sequencing full-length mRNA transcripts has led to a renaissance of long-read mRNA sequencing, now using third-generation DNA sequencers most notably from Pacific Biosciences (PacBio)<xref ref-type="bibr" rid="bib36"><sup>36</sup></xref> and Oxford Nanopore Technologies.<xref ref-type="bibr" rid="bib37"><sup>37</sup></xref> For example, PacBio isoform sequencing (Iso-Seq) has successfully identified many novel transcripts and alternative splicing events in tissues and cell types with well-characterized transcriptomes,<xref ref-type="bibr" rid="bib38">38</xref>, <xref ref-type="bibr" rid="bib39">39</xref> whereas Nanopore RNA-seq has been used for determining exon connectivity and full-length mRNAs in complex alternatively spliced genes with thousands of distinct isoform products.<xref ref-type="bibr" rid="bib40"><sup>40</sup></xref> The strengths of third-generation long-read RNA-seq are in their long read lengths, which allow the direct resolution of isoform structure and the interrogation of repetitive RNA sequences, whereas their main weaknesses are their higher error rates and lower throughput (<xref ref-type="fig" rid="fig2">Figure 2</xref>). For the purpose of analyzing alternative splicing, the higher error rates are tolerable because aligners can leverage the long read lengths to align reads to exons and splice junctions. However, the smaller read number due to the lower throughput is a major bottleneck for the accurate quantitation of isoform abundance. A hybrid approach of combining long, error-prone reads from third-generation sequencers with short, accurate reads from second-generation sequencers has been developed for correcting sequencing errors and obtaining isoform quantitation from long reads.<xref ref-type="bibr" rid="bib38"><sup>38</sup></xref> From a historical perspective, the data of third-generation long-read RNA-seq resemble those of EST sequencing, and computational methods developed for EST data have proven useful for PacBio and Nanopore RNA-seq data.<xref ref-type="bibr" rid="bib41"><sup>41</sup></xref><fig id="fig2"><label>Figure 2</label><caption><p>Strengths and Weaknesses of Short-Read and Long-Read RNA-Seq</p><p>(A) Schematic diagram of an alternatively spliced gene that generates two distinct mRNA isoforms. The first, middle, and last exons are constitutive exons. The second and fourth exons are alternative exons. The two alternative exons are co-spliced such that the long isoform contains all five exons and the short isoform contains only the first, middle, and last exons.</p><p>(B) Short-read RNA-seq generates many reads, enabling the accurate quantitation of individual alternative exons, but the long-range coupling between the two alternative exons is lost.</p><p>(C) Long-read RNA-seq captures the long-range coupling between alternative exons and identifies the correct full-length mRNA isoforms, but the limited number of reads reduces the precision of isoform quantitation.</p></caption><graphic xlink:href="gr2"></graphic></fig></p>
<p id="p0050">Beyond sequencing, imaging is emerging as a powerful technology for transcriptome analysis with spatiotemporal resolution. Sequential fluorescence <italic>in situ</italic> hybridization (seqFISH)<xref ref-type="bibr" rid="bib42"><sup>42</sup></xref> and multiplexed error-robust fluorescence <italic>in situ</italic> hybridization (MERFISH)<xref ref-type="bibr" rid="bib43"><sup>43</sup></xref> are imaging-based methods for single-cell transcriptomics and can quantify hundreds of target transcripts at the single-molecule level with spatial resolution. These methods integrate single-molecule fluorescence <italic>in situ</italic> hybridization with a barcoding scheme to distinguish hundreds of transcripts simultaneously. Each target transcript has a predefined sequential fluorescent barcode, which is used for identifying the transcript via cycles of hybridization with different fluorescent probes. Currently, seqFISH and MERFISH have primarily been applied to gene-level quantification, but with customizable probes, these approaches are in principle applicable to isoform analysis.</p>
</sec>
<sec id="sec1.3">
<title>Quantifying Alternative Splicing by Using RNA-Seq Data</title>
<p id="p0055">Because of the popularity of Illumina RNA-seq, many computational tools have been developed for estimating mRNA isoform expression and quantifying alternative splicing variation with the use of short-read RNA-seq data.<xref ref-type="bibr" rid="bib44">44</xref>, <xref ref-type="bibr" rid="bib45">45</xref> These tools fall into two broad categories according to their strategies for data analysis.</p>
<p id="p0060">The first category represents transcript-based tools that seek to estimate the abundances and relative proportions of full-length mRNA isoforms by using short-read RNA-seq data. This approach typically involves aligning short reads to a reference genome or transcriptome and then estimating the abundances of mRNA isoforms by using an expectation-maximization algorithm.<xref ref-type="bibr" rid="bib46">46</xref>, <xref ref-type="bibr" rid="bib47">47</xref> Recent innovations in pseudo-alignment algorithms have led to alignment-free RNA-seq transcript quantitation with significantly improved speed and computational efficiency.<xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref> Isoform proportions can then be inferred from the estimated abundances of all mRNA isoforms of a given gene. A drawback of the transcript-based approach is that inferring the abundance of full-length mRNA isoforms from short reads is non-trivial, and the results are sensitive to the choice of transcript annotations.<xref ref-type="bibr" rid="bib45"><sup>45</sup></xref> Moreover, for genes with multiple alternatively spliced regions, it is not straightforward to attribute change in the abundance of mRNA isoforms to differential splicing regulation at specific exons or splice sites.</p>
<p id="p0065">The second category represents event-based tools that seek to directly quantify individual alternative splicing events by using RNA-seq data. In this approach, alternative splicing events are discovered from RNA-seq data, reads aligned to specific exons or splice junctions are counted, and appropriate statistical methods are used for quantifying alternative splicing and detecting differential splicing between distinct biological conditions. A widely used metric in event-based analyses is percent spliced in (PSI or ψ), which represents the percentage of a gene’s mRNA transcripts that include a specific exon or splice site.<xref ref-type="bibr" rid="bib50"><sup>50</sup></xref> For a given alternative splicing event, the PSI value can be calculated from the counts of RNA-seq reads supporting specific exons or splice junctions.<xref ref-type="bibr" rid="bib50">50</xref>, <xref ref-type="bibr" rid="bib51">51</xref> Many popular computational tools for RNA-seq analysis of alternative splicing are event based (MISO,<xref ref-type="bibr" rid="bib50"><sup>50</sup></xref> SpliceTrap,<xref ref-type="bibr" rid="bib52"><sup>52</sup></xref> rMATS,<xref ref-type="bibr" rid="bib51"><sup>51</sup></xref> and MAJIQ,<xref ref-type="bibr" rid="bib7"><sup>7</sup></xref> to name a few). These tools differ in their definitions of alternative splicing events (basic versus complex), read-counting procedures, and statistical methods for quantifying and determining differential alternative splicing. Nonetheless, for the same set of alternative splicing events, these tools tend to produce highly concordant PSI estimates.<xref ref-type="bibr" rid="bib53"><sup>53</sup></xref> Given that the PSI value represents a proportion estimated from read counts, the confidence interval of the PSI estimate is dependent on the overall RNA-seq read coverage for an event of interest, such that a higher coverage leads to a more reliable PSI estimate. This is a critical issue in RNA-seq analysis of alternative splicing, and studies have shown that modeling the confidence interval of PSI values on the basis of RNA-seq read counts improves downstream statistical inference.<xref ref-type="bibr" rid="bib50">50</xref>, <xref ref-type="bibr" rid="bib51">51</xref>, <xref ref-type="bibr" rid="bib54">54</xref> Interestingly, a hybrid approach leveraging full-length transcript quantitation for event-based analysis has been employed in a tool called SUPPA.<xref ref-type="bibr" rid="bib53"><sup>53</sup></xref> This tool first runs alignment-free transcript quantitation software to estimate the abundance of mRNA isoforms and then converts these estimates to alternative splicing quantitation at the event level. With the use of pseudo-alignment algorithms,<xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref> this approach is fast and scalable to large datasets. However, it is restricted to pre-existing transcript annotations and cannot discover or quantify novel alternative splicing events. This issue is a limitation for analyzing genetic variation of alternative splicing, given that genomic variants can generate novel alternative splicing events in individual transcriptomes.<xref ref-type="bibr" rid="bib55">55</xref>, <xref ref-type="bibr" rid="bib56">56</xref></p>
</sec>
<sec id="sec1.4">
<title>Computational Approaches for Discovering Genetic Associations of Alternative Splicing</title>
<p id="p0070">With the continued increase in capacity and reduction in cost of high-throughput sequencers, generating RNA-seq datasets across many individuals in a population has become feasible (<xref ref-type="fig" rid="fig3">Figure 3</xref>A). Such population-scale RNA-seq datasets enable transcriptome-wide studies to associate genotypes with alternative splicing variation. Splicing quantitative trait locus (sQTL) analysis is a commonly used approach for discovering genetic variants associated with alternative splicing (<xref ref-type="fig" rid="fig3">Figure 3</xref>B).<xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref>, <xref ref-type="bibr" rid="bib59">59</xref> QTL analyses involve correlating genotypes with quantifiable phenotypes (traits). In sQTL analysis, the quantitative profiles of alternative splicing (e.g., PSI values) are treated as traits and tested for association with genotypes. Several computational methods have been developed for identifying sQTLs from population-scale genotype and RNA-seq data.<xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref>, <xref ref-type="bibr" rid="bib59">59</xref>, <xref ref-type="bibr" rid="bib60">60</xref>, <xref ref-type="bibr" rid="bib61">61</xref> Zhao et al. developed GLiMMPS, a computational method that identifies sQTLs at the event level by associating the PSI values of individual alternative splicing events with genotypes across the population. An important feature of GLiMMPS is that it uses a generalized linear mixed model to model the confidence interval of the PSI value in each individual as a function of RNA-seq coverage, which leads to improved accuracy over competing statistical models that treat the PSI value as a point estimate.<xref ref-type="bibr" rid="bib57"><sup>57</sup></xref> Monlong et al. developed sQTLseekeR, a computational method that identifies sQTLs at the transcript level.<xref ref-type="bibr" rid="bib59"><sup>59</sup></xref> sQTLseekeR treats the relative abundances of all alternatively spliced isoforms of a gene as a vector and uses a distance-based approach to test for association with genotypes. Because this method is applicable to any number of isoforms, it can detect sQTLs arising from both simple and complex alternative splicing events. Notably, the sQTL approach can be used to test for the association between any alternative splicing event and any SNP in <italic>cis</italic> or <italic>trans</italic>.<xref ref-type="bibr" rid="bib62"><sup>62</sup></xref>
<italic>cis</italic>-sQTL analyses could pinpoint genetic variants affecting <italic>cis</italic> splicing regulatory elements. On the other hand, <italic>trans</italic>-sQTL analyses can potentially identify hotspots where a SNP at a single genomic locus affects the alternative splicing of numerous genes across the genome. Such <italic>trans</italic>-sQTL hotspots have the potential to reveal known or novel regulators of alternative splicing.<fig id="fig3"><label>Figure 3</label><caption><p>Strategies for Discovering Genetic Associations of Alternative Splicing</p><p>(A) A population of individuals is genotyped, and their transcriptomes are subject to RNA-seq.</p><p>(B) Splicing quantitative trait locus (sQTL) analysis. For a given exon, the splicing level (PSI value) is measured for each individual on the basis of RNA-seq reads aligned to distinct mRNA isoforms. The PSI values are treated as quantitative traits and tested for association with genotypes across all individuals for the identification of significant sQTLs.</p><p>(C) Allele-specific alternative splicing (ASAS) analysis. Splicing levels (PSI values) are measured in an allele-specific manner for individuals who are heterozygous for a given SNP. For each individual, a PSI measurement can be obtained for each allele on the basis of allele-specific reads aligned to distinct mRNA isoforms. Reproducible allelic differences in PSI values across multiple heterozygous individuals provide evidence for significant ASAS events.</p></caption><graphic xlink:href="gr3"></graphic></fig></p>
<p id="p0075">Allele-specific alternative splicing (ASAS) analysis is a complementary approach to sQTL analysis for discovering genetic variants associated with alternative splicing (<xref ref-type="fig" rid="fig3">Figure 3</xref>C). ASAS analysis aims to identify differential alternative splicing between mRNA transcripts expressed from two haplotypes of an individual. This approach involves using heterozygous SNPs present in mRNAs to assign RNA-seq reads to two alleles and then testing for differential splicing between the two alleles. Such an allele-specific strategy has been applied to different types of alternative RNA processing mechanisms, including alternative splicing.<xref ref-type="bibr" rid="bib63">63</xref>, <xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref> Compared with the sQTL approach, the ASAS approach is unique in that the two alleles are exposed to an identical cellular environment; thus, their splicing differences in the individual can be attributed to <italic>cis</italic> genetic effects. However, for the ASAS approach to work, a heterozygous SNP must be expressed outside of the alternatively spliced region to enable allele-specific read assignment while being sufficiently close to the alternative splicing event to be detected on the same RNA-seq read with this event. As a result of this limitation, certain events might not be accessible with the ASAS approach using short-read RNA-seq data; however, recent work has explored the use of long-read RNA-seq for identifying ASAS events.<xref ref-type="bibr" rid="bib66"><sup>66</sup></xref> In an interesting extension of the conventional ASAS approach applied to RNA-seq data of polyA<sup>+</sup> mRNAs, Hsiao et al. integrated ASAS analysis with polyA<sup>+</sup> and polyA<sup>−</sup> RNA-seq data for distinct subcellular compartments (cytosolic and nuclear).<xref ref-type="bibr" rid="bib67"><sup>67</sup></xref> By examining the allelic ratio of RNA-seq reads from mature cytosolic polyA<sup>+</sup> mRNAs or from nuclear polyA<sup>−</sup> RNAs representing spliced-out products, the authors were able to identify both exonic and intronic variants affecting alternative splicing.</p>
</sec>
<sec id="sec1.5">
<title>Widespread Variation and Phenotypic Association of Alternative Splicing in Human Populations</title>
<p id="p0080">In the last few years, population-scale RNA-seq datasets have been generated for diverse tissues and cell types (<xref ref-type="table" rid="tbl1">Table 1</xref>). Many of the initial RNA-seq studies were performed with lymphoblastoid cell lines (LCLs).<xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib68">68</xref>, <xref ref-type="bibr" rid="bib69">69</xref>, <xref ref-type="bibr" rid="bib71">71</xref>, <xref ref-type="bibr" rid="bib76">76</xref> LCLs are individual-specific immortalized cell lines created through the infection of human B cells with Epstein-Barr virus.<xref ref-type="bibr" rid="bib77"><sup>77</sup></xref> These cell lines have been extensively characterized by large-scale genotyping efforts, such as the HapMap and 1000 Genomes projects.<xref ref-type="bibr" rid="bib78">78</xref>, <xref ref-type="bibr" rid="bib79">79</xref> Therefore, they provide readily available materials for studying the association between genetic variants and gene regulation, including alternative splicing. In two pioneering studies, Pickrell et al. and Montgomery et al. performed RNA-seq of LCLs from African and European populations.<xref ref-type="bibr" rid="bib68">68</xref>, <xref ref-type="bibr" rid="bib69">69</xref> In addition to identifying QTLs affecting overall gene expression levels (expression QTLs or eQTLs), both studies discovered over 100 sQTLs. The largest LCL RNA-seq dataset was generated by the Geuvadis (Genetic European Variation in Health and Disease) Consortium, which performed RNA-seq on 462 LCL samples from five populations from the 1000 Genomes Project.<xref ref-type="bibr" rid="bib64"><sup>64</sup></xref> A major limitation of LCLs, however, is that they represent a single, relatively homogeneous cell type, whereas transcriptome regulation is strongly tissue and cell-type specific. More recently, population-scale RNA-seq studies have been applied to different tissues.<xref ref-type="bibr" rid="bib62">62</xref>, <xref ref-type="bibr" rid="bib70">70</xref>, <xref ref-type="bibr" rid="bib72">72</xref>, <xref ref-type="bibr" rid="bib73">73</xref>, <xref ref-type="bibr" rid="bib74">74</xref>, <xref ref-type="bibr" rid="bib75">75</xref> The most comprehensive effort to date is the GTEx (Genotype-Tissue Expression) Consortium,<xref ref-type="bibr" rid="bib80">80</xref>, <xref ref-type="bibr" rid="bib81">81</xref> which has released raw RNA-seq data along with whole-genome genotype data for over 10,000 tissue samples from 53 tissue sites (GTEx release V7), and this dataset continues to expand. Furthermore, induced pluripotent stem cells (iPSCs) are being explored for RNA-seq-based QTL studies as an alternative to LCLs and tissues.<xref ref-type="bibr" rid="bib82"><sup>82</sup></xref> Not only would human iPSCs be able to replace LCLs as a source of individual-specific, continuously expandable biological materials, but these cells can also be differentiated <italic>in vitro</italic> into many mature cell types, thus circumventing the bottleneck of availability and access in tissue-based RNA-seq studies.<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Population-Scale RNA-Seq Studies of Alternative Splicing Variation in Human Transcriptomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Study</bold></th><th><bold>Tissue or Cell Type</bold></th><th><bold>Sample Size</bold></th><th><bold>Summary</bold></th></tr></thead><tbody><tr><td>Montgomery et al.<xref ref-type="bibr" rid="bib68"><sup>68</sup></xref></td><td>LCLs</td><td>60</td><td>one of the first two population-scale transcriptome genetics studies to use RNA-seq; identified 110 sQTL events in a European population at a 0.01 permutation threshold</td></tr><tr><td>Pickrell et al.<xref ref-type="bibr" rid="bib69"><sup>69</sup></xref></td><td>LCLs</td><td>69</td><td>one of the first two population-scale transcriptome genetics studies to use RNA-seq; identified 187 genes with significant sQTLs in an African population at a 10% FDR, and many of these altered splicing by affecting <italic>cis</italic> splicing regulatory elements</td></tr><tr><td>Lappalainen et al.<xref ref-type="bibr" rid="bib64"><sup>64</sup></xref></td><td>LCLs</td><td>462</td><td>the largest population-scale RNA-seq dataset on LCLs; was generated by the Geuvadis project and included data on four European populations and one African population; identified 639 genes with trQTLs, where the genotype is significantly associated with the ratio of individual transcript level to total gene expression; found that genetic variation of gene expression levels and transcript isoform structure is equally common but largely controlled by independent causal variants</td></tr><tr><td>Battle et al.<xref ref-type="bibr" rid="bib62"><sup>62</sup></xref></td><td>whole blood</td><td>922</td><td>whole blood from the Depression Genes and Networks cohort; identified 1,370 genes with significant sQTLs at a 5% FDR; a total of 159 sQTLs were in high LD with trait- and disease-associated GWAS SNPs; the large sample size also allowed the identification of candidate <italic>trans</italic>-sQTLs</td></tr><tr><td>Fadista et al.<xref ref-type="bibr" rid="bib70"><sup>70</sup></xref></td><td>pancreatic islets</td><td>89</td><td>identified 371 sQTLs, including sQTLs in known T2D-associated loci or in genes associated with beta cell function and glucose metabolism</td></tr><tr><td>Li et al.<xref ref-type="bibr" rid="bib71"><sup>71</sup></xref></td><td>LCLs</td><td>17</td><td>RNA-seq study of a 17-individual, three-generation family; allowed the discovery of sQTLs controlled by rare variants; identified 261 sQTLs at a 50% FDR; found that sQTLs with large effects in the family were enriched with rare variants</td></tr><tr><td>GTEx Consortium<xref ref-type="bibr" rid="bib72"><sup>72</sup></xref></td><td>43 tissues</td><td>1,641</td><td>data from the pilot phase of the GTEx project: 1,641 samples from 43 tissues across 175 individuals; identified an average of ∼1,900 and ∼250 sQTL genes per tissue with Altrans<xref ref-type="bibr" rid="bib58"><sup>58</sup></xref> and sQTLseekeR,<xref ref-type="bibr" rid="bib59"><sup>59</sup></xref> respectively; most sQTL genes were not eQTL genes; significant sQTLs tended to be shared among tissues, whereas tissue-specific sQTLs represented only 7%–21% of sQTLs, depending on the tissue type</td></tr><tr><td>Chen et al.<xref ref-type="bibr" rid="bib73"><sup>73</sup></xref></td><td>monocytes, neutrophils, and T cells</td><td>197</td><td>CD14<sup>+</sup> monocytes, CD16<sup>+</sup> neutrophils, and naive CD4<sup>+</sup> T cells from up to 197 individuals; quantified splicing by using both PSI event-based measurements and relative abundances of transcript isoforms; identified over 2,000 genes with sQTLs at a 5% FDR in each of the three cell types</td></tr><tr><td>Pala et al.<xref ref-type="bibr" rid="bib74"><sup>74</sup></xref></td><td>leukocytes</td><td>624</td><td>included a total of 624 individuals from Sardinia; first sQTL study to integrate whole-genome and RNA-seq data of multiple families to discover common and rare variants affecting splicing; identified 6,768 sQTLs</td></tr><tr><td>Takata et al.<xref ref-type="bibr" rid="bib75"><sup>75</sup></xref></td><td>brain (prefrontal cortex)</td><td>206</td><td>identified 1,595 sQTLs in 1,341 unique genes; significant sQTLs were enriched with disease-associated GWAS loci, particularly loci associated with schizophrenia</td></tr></tbody></table><table-wrap-foot><fn><p>The following abbreviations are used: FDR, false discovery rate; T2D, type 2 diabetes; and trQTL, transcript ratio QTL.</p></fn></table-wrap-foot></table-wrap></p>
<p id="p0085">Using these large-scale datasets, researchers have begun to define the landscape, genetic architecture, and phenotypic association of alternative splicing variation in human populations (<xref ref-type="table" rid="tbl1">Table 1</xref>). Despite the differences in tissue and cell type, sample size, and sequencing depth, as well as the computational methods used for discovering sQTLs, several consensuses have emerged. These studies demonstrate that inheritable genetic variation of alternative splicing is widespread across diverse human tissues and cell types. Although sQTL SNPs tend to be enriched at the essential 5′ and 3′ splice sites,<xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib69">69</xref>, <xref ref-type="bibr" rid="bib72">72</xref> many sQTLs can be attributed to SNPs located outside of the splice site regions. These SNPs can modify splicing enhancer or silencer elements as well as known RBP binding sites in exonic or intronic regions.<xref ref-type="bibr" rid="bib83"><sup>83</sup></xref> The approach of coupling sQTL results to GWAS signals has identified a large number of sQTLs in high linkage disequilibrium (LD) with previously identified GWAS SNPs (<xref ref-type="table" rid="tbl1">Table 1</xref>), suggesting that SNPs affecting alternative splicing could be the causal variants underlying a substantial fraction of GWAS signals for complex traits and diseases. For example, an RNA-seq study of 206 human brain (prefrontal cortex) tissues reported significant enrichment of sQTLs among GWAS disease loci, particularly for GWAS SNPs associated with schizophrenia.<xref ref-type="bibr" rid="bib75"><sup>75</sup></xref> Similarly, an RNA-seq study of 89 pancreatic islets identified sQTLs in known type-2-diabetes-associated loci.<xref ref-type="bibr" rid="bib70"><sup>70</sup></xref> One key question is whether sQTLs identified in these studies are the primary contributors to GWAS-associated traits and diseases or merely reflect the secondary effects of SNPs that affect phenotypes via other layers of gene regulation. To address this question, an elegant study by Li et al. integrated multiple datasets to analyze eight types of regulatory QTLs in a cohort of LCLs from an African population.<xref ref-type="bibr" rid="bib84"><sup>84</sup></xref> The authors found that most sQTLs are independent of eQTLs, and sQTLs appear to have a comparable or even greater magnitude of effects on GWAS traits than eQTLs. These data suggest that splicing is a primary link between genetic variation and complex diseases, consistent with the prevalence of aberrant splicing as a primary cause of Mendelian diseases.<xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib17">17</xref></p>
<p id="p0090">Two examples of sQTLs that correlate with GWAS signals are highlighted here. <italic>SP140</italic> is a tissue-restricted gene with high expression in lymphoid cells,<xref ref-type="bibr" rid="bib85"><sup>85</sup></xref> and its domain structure suggests a role in chromatin-mediated regulation of gene expression.<xref ref-type="bibr" rid="bib86"><sup>86</sup></xref> Several GWASs identified <italic>SP140</italic> SNPs that are significantly associated with chronic lymphocytic leukemia,<xref ref-type="bibr" rid="bib87"><sup>87</sup></xref> multiple sclerosis,<xref ref-type="bibr" rid="bib88"><sup>88</sup></xref> Crohn disease,<xref ref-type="bibr" rid="bib89"><sup>89</sup></xref> and inflammatory bowel disease.<xref ref-type="bibr" rid="bib90"><sup>90</sup></xref> However, the causal mechanism underlying these GWAS signals remained unknown. On the basis of sQTL analysis of RNA-seq data of LCLs from a European population, a significant sQTL signal was found for exon 7 of <italic>SP140</italic>, and the peak SNP was a C-to-T exonic SNP, rs28445040 (<xref ref-type="fig" rid="fig4">Figures 4</xref>A and 4B).<xref ref-type="bibr" rid="bib57"><sup>57</sup></xref> Although this SNP does not alter the encoded protein sequence of <italic>SP140</italic>, minigene splicing reporter assays demonstrated its role in regulating the splicing level of <italic>SP140</italic> exon 7, such that the T allele is associated with significantly reduced exon inclusion.<xref ref-type="bibr" rid="bib57"><sup>57</sup></xref> Because the exon is 78 bp in length, skipping of this exon would remove an in-frame 26 amino acid peptide from the protein product without affecting the downstream reading frame. Strikingly, this SNP is in high LD with GWAS SNPs of all four diseases (<xref ref-type="fig" rid="fig4">Figure 4</xref>C), suggesting that this is the causal variant underlying the association between <italic>SP140</italic> and these diseases. Furthermore, the association between this sQTL and multiple sclerosis was replicated in a recent case-control study.<xref ref-type="bibr" rid="bib92"><sup>92</sup></xref> In another example, several studies identified an sQTL in exon 10 of <italic>ERAP2</italic>,<xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib93">93</xref>, <xref ref-type="bibr" rid="bib94">94</xref> a gene encoding a protease that processes antigenic epitopes for MHC class I antigen presentation.<xref ref-type="bibr" rid="bib95"><sup>95</sup></xref> An A-to-G intronic SNP (rs2248374) within the 5′ splice site of <italic>ERAP2</italic> deactivates the canonical 5′ splice site and activates a downstream cryptic 5′ splice site. This change leads to the production of an aberrant transcript that contains a premature termination codon subject to nonsense-mediated mRNA decay. RNA-seq data of LCLs indicate a significant switch in splicing among different genotypes of rs2248374, along with a significant change in steady-state mRNA levels due to alternative-splicing-coupled mRNA decay (<xref ref-type="fig" rid="fig4">Figures 4</xref>D and 4E). The G allele is associated with lower levels of MHC class I molecules at the surface of B cells<xref ref-type="bibr" rid="bib94"><sup>94</sup></xref> and is in LD with GWAS signals for several diseases, such as Crohn disease<xref ref-type="bibr" rid="bib89"><sup>89</sup></xref> and inflammatory bowel disease<xref ref-type="bibr" rid="bib90"><sup>90</sup></xref> (<xref ref-type="fig" rid="fig4">Figure 4</xref>F). These two examples are just the tip of the iceberg for many sQTLs identified across various studies, and they illustrate that sQTLs can influence complex traits and diseases by altering protein activity and function (<italic>SP140</italic>) or mRNA stability and steady-state mRNA levels (<italic>ERAP2</italic>). It is also worth noting that the causal variants for these two GWAS-associated sQTLs are silent exonic (<italic>SP140</italic>) or intronic (<italic>ERAP2</italic>) and would therefore be missed by many commonly used tools for variant annotation.<xref ref-type="bibr" rid="bib96"><sup>96</sup></xref><fig id="fig4"><label>Figure 4</label><caption><p>Two Examples of sQTLs Associated with GWAS Signals for Complex Diseases</p><p>(A–C) Alternative splicing of <italic>SP140</italic> exon 7 is associated with chronic lymphocytic leukemia, Crohn disease, inflammatory bowel disease, and multiple sclerosis. The alternative splicing event is an exon-skipping event. The C allele is associated with a higher level of exon inclusion, whereas the T allele is associated with a higher level of exon skipping. (A) Boxplot showing the significant association between SNP rs28445040 and the splicing level (PSI value) of <italic>SP140</italic> exon 7 within the Geuvadis CEU (Utah residents with ancestry from northern and western Europe) population. Each dot represents the PSI value from a particular individual, and the size of each dot is proportional to the RNA-seq read coverage for the alternative splicing event in that individual. (B) Sashimi plot indicating the average RNA-seq read density and splice junction counts for each genotype. Exons and introns are not drawn to scale, and the relative width of exons is increased for clarity. (C) LD plot showing multiple GWAS SNPs (green boxes) linked with the sQTL SNP (purple box).</p><p>(D–F) Alternative splicing of <italic>ERAP2</italic> exon 10 is associated with Crohn disease, ulcerative colitis, inflammatory bowel disease, and birdshot chorioretinopathy. The alternative splicing event is an alternative 5′ splice site event. The A allele is associated with a higher level of the upstream canonical 5′ splice site, whereas the G allele is associated with a higher level of the downstream cryptic 5′ splice site. Usage of the downstream cryptic 5′ splice site introduces a premature stop codon and results in nonsense-mediated mRNA decay. (D) Boxplot showing the significant association between SNP rs2248374 and the splicing level (PSI value) of <italic>ERAP2</italic> exon 10 (i.e., usage of the downstream cryptic 5′ splice site) within the Geuvadis CEU population. Each dot represents the PSI value from a particular individual, and the size of each dot is proportional to the RNA-seq read coverage for the alternative splicing event in that individual. (E) Sashimi plot indicating the average RNA-seq read density and splice junction counts for each genotype. Exons and introns are not drawn to scale, and the relative width of exons is increased for clarity. (F) LD plot showing multiple GWAS SNPs (green boxes) linked with the sQTL SNP (purple box).</p><p>RNA-seq data of 89 CEU individuals are from the Geuvadis project.<xref ref-type="bibr" rid="bib64"><sup>64</sup></xref> Sashimi plots were drawn with rmats2sashimiplot (see <xref ref-type="sec" rid="app1">Web Resources</xref>). LD plots were drawn with Haploview 4.2<xref ref-type="bibr" rid="bib91"><sup>91</sup></xref> and include CEU individuals from the 1000 Genomes Project (phase 3). For each boxplot, the top and bottom of the box represent the third and first quartiles, respectively. The band in the middle of the box represents the median. The whiskers of each boxplot extend to the most extreme data points within 1.5 times the interquartile range from each box.</p></caption><graphic xlink:href="gr4"></graphic></fig></p>
</sec>
<sec id="sec1.6">
<title>Characterizing Causal Variants of Alternative Splicing via Massively Parallel Reporter Assays</title>
<p id="p0095">Although RNA-seq can reveal associations between genetic variants and alternative splicing, identifying the causal variants underlying the detected associations remains a challenging task. In an sQTL analysis, multiple variants within a haplotype block can be significantly associated with alternative splicing, but we do not know which variant(s) causally affect(s) splicing regulation. A widely used molecular biology approach to the study of splicing regulation is the minigene splicing reporter assay.<xref ref-type="bibr" rid="bib97"><sup>97</sup></xref> A minigene splicing reporter is constructed via the insertion of a piece of genomic DNA that contains the exon of interest and its flanking intronic sequences into a position where it is flanked either by exons from another gene (i.e., heterologous minigene reporter) or by the upstream and downstream constitutive exons from the same gene (<xref ref-type="fig" rid="fig5">Figure 5</xref>A). Site-directed mutagenesis within a minigene splicing reporter can be used for assessing the impact of specific genomic variants or splicing regulatory elements (<xref ref-type="fig" rid="fig5">Figure 5</xref>B). Coupled with high-throughput screens, minigene splicing reporters can be used for identifying splicing enhancer or silencer elements and discovering <italic>trans</italic>-acting factors or small-molecule compounds that regulate the splicing of specific exons.<fig id="fig5"><label>Figure 5</label><caption><p>Experimental and Computational Tools for Characterizing the Causal Impacts of Genomic Variants on Alternative Splicing</p><p>(A) Schematic diagram of a minigene splicing reporter. An exon of interest, along with its flanking intronic sequences, is inserted into a splicing reporter construct, where it is flanked by upstream and downstream exons containing a promoter and a polyA site. The splicing profile of the minigene splicing reporter can be determined by RT-PCR or RNA-seq.</p><p>(B) Use of minigene splicing reporters for characterizing the effects of disease-causing variants or exonic and intronic splicing regulatory elements on splicing.</p><p>(C) Minigene splicing reporters can be used in massively parallel reporter assays (MPRAs) for determining the consequences of many sequence variants on splicing in a high-throughput manner. A library of minigenes is transfected into a cell line, and splicing levels are measured for all variants simultaneously by RNA-seq.</p><p>(D) Deep learning framework for analyzing alternative splicing. Starting with input data, including the genome sequence and RNA-seq data, the framework extracts genomic and RNA features. These features include diverse types of quantitative or qualitative features, such as conservation score, sequence motifs, secondary structure, and epigenetic marks. A computational model is trained to predict splicing patterns and levels by using the extracted features. The predictions can be evaluated with experimental validation (e.g., by RNA-seq, RT-PCR, or minigene).</p></caption><graphic xlink:href="gr5"></graphic></fig></p>
<p id="p0100">With recent advances in oligonucleotide synthesis technologies and high-throughput sequencing, massively parallel reporter assays (MPRAs) have become an increasingly popular approach to the study of gene regulation, including alternative splicing.<xref ref-type="bibr" rid="bib98"><sup>98</sup></xref> MPRAs test the functional impacts of many sequence variants in parallel. These sequences are inserted into a reporter construct and transfected into cells or combined with cellular extracts for determining the functional impacts of sequence variants (<xref ref-type="fig" rid="fig5">Figure 5</xref>C). Two recent studies conducted MPRAs with minigene splicing reporters to determine the effects of <italic>cis</italic> sequence variants on splicing.<xref ref-type="bibr" rid="bib99">99</xref>, <xref ref-type="bibr" rid="bib100">100</xref> Rosenberg et al. tested over two million synthetic minigenes in a high-throughput fashion.<xref ref-type="bibr" rid="bib99"><sup>99</sup></xref> Specifically, they created two separate libraries to study alternative 5′ or 3′ splice sites and analyzed the ability of random sequences to influence splice site selection. The authors split a single-gene sequence (Citrine, a derivative of YFP) into two exons as the backbone of the reporter and inserted introns with degenerate sequences between the two exons. For the alternative 5′ splice site library, each intron was designed to have two competing alternative 5′ splice sites, and two random 25 bp sequences were inserted into positions between the two competing 5′ splice sites or downstream of the distal 5′ splice site. The library for alternative 3′ splice site analysis was designed in the same manner. The resulting libraries were transfected into cells, and the splicing profiles of all sequences were measured in parallel by RNA-seq. Leveraging the abundant synthetic reporter data, the authors were able to use machine learning to model splicing patterns and predict the effects of human SNPs on splicing. Interestingly, the models learned from alternative 5′ and 3′ splice sites can also predict exon skipping <italic>in vivo</italic>. In another study, Soemedi et al. developed a massively parallel splicing assay (MaPSy) to interrogate the effects of 4,964 exonic disease-causing mutations on alternative splicing.<xref ref-type="bibr" rid="bib100"><sup>100</sup></xref> The authors synthesized a 170 bp genomic sequence library for all mutant and wild-type exon pairs. Disease-mutation-containing exons that were less than or equal to 100 bp in length were selected and synthesized to include at least 55 bp of the upstream intron and at least 15 bp of the downstream intron. Two parallel assays were performed. The first assay tested the impact of the mutation on the exon's inclusion or skipping <italic>in vivo</italic> when the reporter was transfected into cells, and the second tested whether the mutation influenced the splicing of the upstream intron <italic>in vitro</italic> when the sequence was incubated with nuclear extracts. Even though they used distinct experimental systems, the two assays reached general agreement. Approximately 10% of the tested disease-causing mutations perturbed splicing in both assays. By contrast, only 3% of common SNPs perturbed splicing in both assays. This 10% is most likely a lower-bound estimate for the percentage of pathogenic exonic mutations that disrupt splicing, considering the cell-type-specific nature of splicing regulation and that only a single cell type (HEK293) was used for the <italic>in vivo</italic> assay.</p>
<p id="p0105">MPRAs provide a powerful tool for characterizing the causal genetic variants of alternative splicing. A major advantage of MPRAs is that these experiments generate a massive amount of data. As demonstrated by Rosenberg et al.,<xref ref-type="bibr" rid="bib99"><sup>99</sup></xref> these data-rich experiments can be coupled with computational modeling for learning important features of splicing regulation and predicting the impact of <italic>cis</italic> variants on splicing. Additionally, although both studies performed MPRA experiments in the HEK293 cell line, these reporters can be transfected into other cell lines for determining the splicing effects of <italic>cis</italic> variants in other cell types. Moreover, MPRAs can be coupled with sQTL analyses for identifying causal variants underlying sQTL signals, or they can be utilized in clinical exome or genome sequencing studies for identifying splicing-altering variants in disease-affected individuals. One inherent limitation of MPRAs is that the reporter system might not completely recapitulate the exact cellular environment that allows splicing to occur. For example, factors such as chromatin states, DNA methylation, and histone marks are known to influence alternative splicing.<xref ref-type="bibr" rid="bib101"><sup>101</sup></xref> CRISPR-Cas9-based genome editing could address these issues and has been used in recent work for characterizing splicing regulatory elements in endogenous genes.<xref ref-type="bibr" rid="bib102"><sup>102</sup></xref> MPRAs are also limited by the ability to generate libraries; thus, not all exons or variants are assessable by current systems. Future improvements in oligonucleotide synthesis technologies could address this limitation and allow a broader set of exons and deep intronic variants to be examined.</p>
</sec>
<sec id="sec1.7">
<title>Alternative Splicing Meets Machine Learning</title>
<p id="p0110">There has been a long-standing interest in developing <italic>in silico</italic> methods of predicting alternative splicing. The basic scientific premise is that there exists a “splicing code,” a set of genomic and RNA features and associated rules that determine the splicing pattern of any primary transcript in a given cell type.<xref ref-type="bibr" rid="bib12"><sup>12</sup></xref> Machine learning serves the general purpose of learning underlying patterns from data to allow pattern recognition, classification, and prediction. In computational biology, machine learning has been extensively employed in genomics, transcriptomics, proteomics, and other domains.<xref ref-type="bibr" rid="bib103"><sup>103</sup></xref> For example, algorithms have been developed to predict regulatory elements such as promoters, enhancers, and splice sites.<xref ref-type="bibr" rid="bib103"><sup>103</sup></xref></p>
<p id="p0115">Shortly after the EST-based discovery of widespread alternative splicing, several studies applied machine learning methods to predict a binary classification of alternative versus constitutive exons.<xref ref-type="bibr" rid="bib104">104</xref>, <xref ref-type="bibr" rid="bib105">105</xref>, <xref ref-type="bibr" rid="bib106">106</xref>, <xref ref-type="bibr" rid="bib107">107</xref> Alternative exons have distinct sequence features such as exon and intron length, splice site strength, divisibility by three, sequence conservation within exonic and flanking intronic regions, and composition of oligonucleotides reflecting splicing regulatory elements.<xref ref-type="bibr" rid="bib107"><sup>107</sup></xref> Machine learning methods can leverage these features to predict whether an exon undergoes alternative splicing.<xref ref-type="bibr" rid="bib104">104</xref>, <xref ref-type="bibr" rid="bib105">105</xref>, <xref ref-type="bibr" rid="bib106">106</xref>, <xref ref-type="bibr" rid="bib107">107</xref></p>
<p id="p0120">In a landmark study, Barash et al. used quantitative splicing microarray data across 27 mouse tissues to predict tissue-specific patterns of alternative splicing.<xref ref-type="bibr" rid="bib108"><sup>108</sup></xref> They grouped the 27 tissues into four broad categories and converted the PSI value of each exon for each tissue category into three probabilities representing an increase, a decrease, or no change in exon inclusion in that tissue category. Then, the authors collected 1,014 features representing RNA sequence motifs and transcript features. They applied a single-layer logistic Bayesian network that models how individual features cooperate or compete to influence splicing in each tissue type. Importantly, the resulting splicing code can reveal novel regulatory features and predict mutation-induced changes in splicing patterns. This work represents a breakthrough in the field because it was the first demonstration that <italic>in silico</italic> models can successfully predict tissue-regulated alternative splicing. After this work, Xiong et al. added hidden layers to the Bayesian network to construct a Bayesian neural network (BNN).<xref ref-type="bibr" rid="bib109"><sup>109</sup></xref> These hidden layers helped the authors model non-linear relationships between features, leading to an improved prediction accuracy. Based on the BNN framework, the web tool AVISPA was constructed for splicing prediction and analysis and was trained with more data and an expanded feature set.<xref ref-type="bibr" rid="bib110"><sup>110</sup></xref></p>
<p id="p0125">Recently, deep learning, a state-of-the-art machine learning technology, has been applied to predicting alternative splicing<xref ref-type="bibr" rid="bib111">111</xref>, <xref ref-type="bibr" rid="bib112">112</xref>, <xref ref-type="bibr" rid="bib113">113</xref> (<xref ref-type="fig" rid="fig5">Figure 5</xref>D). Deep learning refers to methods that map raw input feature data to increasingly abstract feature representations, where higher layers contain more abstract representations.<xref ref-type="bibr" rid="bib114"><sup>114</sup></xref> Compared with canonical machine learning methods, deep learning is capable of automatically learning complex functions without a need for handcrafted features or rules, and it scales well to large and high-dimensional datasets.<xref ref-type="bibr" rid="bib114">114</xref>, <xref ref-type="bibr" rid="bib115">115</xref> Deep learning has been successfully applied in a variety of fields, including image classification and speech recognition<xref ref-type="bibr" rid="bib114"><sup>114</sup></xref> and more recently in computational biology.<xref ref-type="bibr" rid="bib115"><sup>115</sup></xref> In two studies, Frey and colleagues used RNA-seq data from mouse and human tissues to construct deep learning models that predict the splicing levels of individual exons across different tissues<xref ref-type="bibr" rid="bib111"><sup>111</sup></xref> and the effects of <italic>cis</italic> genetic variants on splicing.<xref ref-type="bibr" rid="bib112"><sup>112</sup></xref> Unlike their previous work that treated tissue-specific splicing patterns as categorical data,<xref ref-type="bibr" rid="bib108"><sup>108</sup></xref> these new methods attempted to predict the numerical PSI values for each exon in each tissue.<xref ref-type="bibr" rid="bib111">111</xref>, <xref ref-type="bibr" rid="bib112">112</xref> Evaluations using independent RNA-seq datasets showed good agreement (R<sup>2</sup> = 0.65) between predicted and empirical PSI values.<xref ref-type="bibr" rid="bib112"><sup>112</sup></xref> The authors then applied the deep learning model to predict the effects of <italic>cis</italic> genetic variants on RNA splicing. Their predictions on clinical variants of selected exons matched well with data from minigene splicing reporters. Furthermore, they applied their model to genome sequencing data of people with autism spectrum disorder (ASD) and control individuals and predicted misregulated splicing in 19 candidate genes with ASD-related neuronal functions. This study demonstrates that deep-learning-based modeling of splicing provides a powerful tool for annotating clinical variants and elucidating the genetic determinants of complex diseases.<xref ref-type="bibr" rid="bib112"><sup>112</sup></xref> In another interesting application, Huang et al. developed a method called BRIE, which learns prior information from RNA sequence features to augment splicing quantification by using single-cell RNA-seq data.<xref ref-type="bibr" rid="bib116"><sup>116</sup></xref></p>
<p id="p0130">With the rapid accumulation of RNA-seq data and RBP-RNA interaction maps in the public domain,<xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib117">117</xref> future work should take advantage of more comprehensive training data and feature space coupled with more advanced machine learning frameworks to improve <italic>in silico</italic> prediction of alternative splicing. As a step in this direction, Jha et al. recently developed a new deep learning framework to integrate additional RNA genomics data, such as CLIP-seq data of RBP-RNA interactions, and RNA-seq data after the knockdown or overexpression of RBPs.<xref ref-type="bibr" rid="bib113"><sup>113</sup></xref> The integrative model generalizes well for RBP perturbation data and improves the accuracy of alternative splicing prediction.<xref ref-type="bibr" rid="bib113"><sup>113</sup></xref> Another interesting direction for future work is to incorporate chromatin states, epigenetic marks, and 3D genome organization in a predictive model, given that splicing is a co-transcriptional process and these features influence splicing via a variety of molecular mechanisms.<xref ref-type="bibr" rid="bib101"><sup>101</sup></xref></p>
<p id="p0135">In addition to using machine learning techniques to directly predict splicing patterns and PSI values, other studies have adopted an alternative strategy of predicting splicing-altering genomic variants by using prior variant annotations as training data.<xref ref-type="bibr" rid="bib118">118</xref>, <xref ref-type="bibr" rid="bib119">119</xref>, <xref ref-type="bibr" rid="bib120">120</xref>, <xref ref-type="bibr" rid="bib121">121</xref> The basic idea is to collect variants known to affect splicing and/or cause human diseases along with common “splicing-neutral” variants that are likely to have no effect on splicing and then build classifiers to distinguish these two categories of variants. The potential shortcomings of these approaches are that the classification of positive versus negative training data might not be accurate and that the results might suffer from selection bias or overfitting. Nonetheless, these tools offer a complementary strategy for evaluating the potential effects of genomic variants on splicing. An interesting method called ExonImpact was recently developed to prioritize disease-associated splicing-altering variants on the basis of the predicted effects of alternative splicing at the protein level.<xref ref-type="bibr" rid="bib121"><sup>121</sup></xref> The rationale behind this work is that not all aberrant splicing events are equally detrimental at the protein level, and pathogenic splicing mutations have distinct protein features that can be incorporated into the predictive model.<xref ref-type="bibr" rid="bib121"><sup>121</sup></xref></p>
</sec>
<sec id="sec1.8">
<title>Alternative Splicing for Disease Diagnosis</title>
<p id="p0140">Given the importance of splicing in disease pathogenesis and progression, several therapeutic strategies have been pursued for correcting splicing defects in disease.<xref ref-type="bibr" rid="bib17"><sup>17</sup></xref> A notable success is the recent FDA approval of nusinersen, an antisense oligonucleotide drug for correcting splicing in spinal muscular atrophy.<xref ref-type="bibr" rid="bib122"><sup>122</sup></xref></p>
<p id="p0145">New data are emerging that alternative splicing might provide diagnostic biomarkers for disease status or outcome.<xref ref-type="bibr" rid="bib26"><sup>26</sup></xref> An example of the predictive power of alternative splicing for disease prognosis was demonstrated in two recent studies showing that alternative splicing profiles can predict cancer patients’ survival time at a comparable and often better accuracy than gene expression levels.<xref ref-type="bibr" rid="bib54">54</xref>, <xref ref-type="bibr" rid="bib123">123</xref> One possible explanation for these observations is the intrinsic feature of alternative splicing data. Given that alternative splicing is quantified as the relative ratio of multiple isoforms from a single gene, alternative splicing data are self-normalized on a per-gene basis and can be viewed as having an “internal control” that could provide a more robust molecular signature than gene expression levels, especially for large clinical RNA-seq datasets that are prone to technical biases and confounding issues.<xref ref-type="bibr" rid="bib54"><sup>54</sup></xref> Consistent with these observations, a new study reported that alternative-splicing-based classifiers generally outperform gene-expression-based classifiers for a wide range of biological classification problems.<xref ref-type="bibr" rid="bib124"><sup>124</sup></xref></p>
<p id="p0150">In a major advance with broad implications, Cummings et al. demonstrated the potential of RNA-seq and alternative splicing analysis for diagnosing rare diseases.<xref ref-type="bibr" rid="bib55"><sup>55</sup></xref> The authors analyzed the muscle transcriptomes of 63 individuals with muscle disorders and compared their RNA-seq data with GTEx RNA-seq data of 184 control muscle samples. Of the 63 individuals with muscle disorders, 50 were genetically undiagnosed. Strikingly, through RNA-seq analysis, the authors obtained a genetic diagnosis for 35% of the previously undiagnosed individuals by identifying novel disease-associated aberrant splicing events in known disease-associated genes. In four individuals, a recurrent aberrant splicing event was discovered in <italic>COL6A1</italic>, in which a GC-to-GT genetic variant created a novel 5′ splice site, leading to the exonization of a 72 bp intronic segment that disrupted the <italic>COL6A1</italic> protein product. This variant would not be easily identifiable by exome or genome sequencing alone, given that exome sequencing would miss this deep intronic variant, and genome sequencing would identify too many variants, making it difficult to determine their pathogenicity in the absence of RNA-seq information. Thus, this study offers an important proof of concept that alternative splicing analysis via the integration of RNA-seq with exome or genome sequencing improves disease diagnosis.</p>
</sec>
<sec id="sec1.9">
<title>Conclusions</title>
<p id="p0155">The past decade since the advent of RNA-seq has seen tremendous growth in the amount of human transcriptome data. Advances in RNA-seq technologies and computational methods have transformed the study of alternative splicing in health and disease. Population-scale RNA-seq studies have discovered many naturally occurring genomic variants that modulate alternative splicing. Many of these variants are associated with GWAS signals, suggesting a ubiquitous contribution of alternative splicing to phenotypic variability and disease susceptibility in human populations. These genetically regulated, GWAS-associated mRNA isoforms are prime candidates for functional studies of alternative splicing. Future work using isoform-specific gain-of-function or loss-of-function assays should elucidate how genetic variation of alternative splicing affects gene functions and consequently cellular and organismal phenotypes.</p>
<p id="p0160">The prevalent role of alternative splicing in Mendelian and complex diseases suggests that evaluating the impact of genomic variants on splicing needs to be an integral part of clinical variant prioritization. Many computational tools and online resources exist for prioritizing and annotating variants discovered by exome or genome sequencing.<xref ref-type="bibr" rid="bib96"><sup>96</sup></xref> Most tools are designed to predict the pathogenic effects of missense variants on protein products. However, there is overwhelming evidence that missense, nonsense, and silent variants within exons, as well as intronic variants, can disrupt splicing and cause disease.<xref ref-type="bibr" rid="bib14"><sup>14</sup></xref> Currently, it is challenging to predict the pathogenic effects of splicing variants within exonic and intronic regions, except for variants affecting the conserved splice site signals, and they are thus ignored by many commonly used pipelines for variant assessment.<xref ref-type="bibr" rid="bib96"><sup>96</sup></xref> Recent advances in experimental (e.g., MPRAs) and computational (e.g., deep learning) tools will allow researchers and clinicians to screen a large number of variants for their effects on splicing in a systematic and unbiased manner. Beyond SNPs, other non-SNP variants such as indels or short tandem repeats can modify <italic>cis</italic> splicing regulatory elements and affect alternative splicing.<xref ref-type="bibr" rid="bib125">125</xref>, <xref ref-type="bibr" rid="bib126">126</xref> The genetic associations between these non-SNP variants and alternative splicing can also be discovered and characterized by the computational and experimental approaches described in this review. A comprehensive catalog of alternative splicing variation in human populations, along with the ability to discover and characterize splicing-altering variants in specific individuals, holds great value for improving disease diagnoses and ultimately patient care in the era of sequencing and precision medicine.</p>
</sec>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharp</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Split genes and RNA splicing</article-title>
<source/>Cell
          <volume>77</volume>
<year>1994</year>
<fpage>805</fpage>
<lpage>815</lpage>
<pub-id pub-id-type="pmid">7516265</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsen</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Graveley</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Expansion of the eukaryotic proteome by alternative splicing</article-title>
<source/>Nature
          <volume>463</volume>
<year>2010</year>
<fpage>457</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="pmid">20110989</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<collab>ENCODE Project Consortium</collab>
</person-group>
<article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
<source/>Nature
          <volume>489</volume>
<year>2012</year>
<fpage>57</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">22955616</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djebali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Merkel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dobin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lassmann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mortazavi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tanzer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lagarde</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Landscape of transcription in human cells</article-title>
<source/>Nature
          <volume>489</volume>
<year>2012</year>
<fpage>101</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="pmid">22955620</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Shai</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing</article-title>
<source/>Nat. Genet.
          <volume>40</volume>
<year>2008</year>
<fpage>1413</fpage>
<lpage>1415</lpage>
<pub-id pub-id-type="pmid">18978789</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Sandberg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khrebtukova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mayr</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kingsmore</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Schroth</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Alternative isoform regulation in human tissue transcriptomes</article-title>
<source/>Nature
          <volume>456</volume>
<year>2008</year>
<fpage>470</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="pmid">18978772</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaquero-Garcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Barrera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gazzara</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>González-Vallinas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lahens</surname>
<given-names>N.F.</given-names>
</name>
<name>
<surname>Hogenesch</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Barash</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>
<source/>eLife
          <volume>5</volume>
<year>2016</year>
<fpage>e11752</fpage>
<pub-id pub-id-type="pmid">26829591</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmucker</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Clemens</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Worby</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Muda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Zipursky</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity</article-title>
<source/>Cell
          <volume>101</volume>
<year>2000</year>
<fpage>671</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="pmid">10892653</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braunschweig</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gueroussov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Plocik</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Graveley</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Dynamic integration of splicing within gene regulatory pathways</article-title>
<source/>Cell
          <volume>152</volume>
<year>2013</year>
<fpage>1252</fpage>
<lpage>1269</lpage>
<pub-id pub-id-type="pmid">23498935</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelemen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Convertini</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Falaleeva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stamm</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Function of alternative splicing</article-title>
<source/>Gene
          <volume>514</volume>
<year>2013</year>
<fpage>1</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">22909801</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalsotra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Functional consequences of developmentally regulated alternative splicing</article-title>
<source/>Nat. Rev. Genet.
          <volume>12</volume>
<year>2011</year>
<fpage>715</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="pmid">21921927</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Splicing regulation: from a parts list of regulatory elements to an integrated splicing code</article-title>
<source/>RNA
          <volume>14</volume>
<year>2008</year>
<fpage>802</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="pmid">18369186</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>X.D.</given-names>
</name>
<name>
<surname>Ares</surname>
<given-names>M.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>Context-dependent control of alternative splicing by RNA-binding proteins</article-title>
<source/>Nat. Rev. Genet.
          <volume>15</volume>
<year>2014</year>
<fpage>689</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="pmid">25112293</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Baralle</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Genomic variants in exons and introns: identifying the splicing spoilers</article-title>
<source/>Nat. Rev. Genet.
          <volume>5</volume>
<year>2004</year>
<fpage>389</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="pmid">15168696</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Splicing in disease: disruption of the splicing code and the decoding machinery</article-title>
<source/>Nat. Rev. Genet.
          <volume>8</volume>
<year>2007</year>
<fpage>749</fpage>
<lpage>761</lpage>
<pub-id pub-id-type="pmid">17726481</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osborne</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>RNA-dominant diseases</article-title>
<source/>Hum. Mol. Genet.
          <volume>15</volume>
<year>2006</year>
<fpage>R162</fpage>
<lpage>R169</lpage>
<pub-id pub-id-type="pmid">16987879</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scotti</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>RNA mis-splicing in disease</article-title>
<source/>Nat. Rev. Genet.
          <volume>17</volume>
<year>2016</year>
<fpage>19</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">26593421</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Percifield</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stoilov</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Medium throughput analysis of alternative splicing by fluorescently labeled RT-PCR</article-title>
<source/>Methods Mol. Biol.
          <volume>1126</volume>
<year>2014</year>
<fpage>299</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">24549673</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Modrek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>A genomic view of alternative splicing</article-title>
<source/>Nat. Genet.
          <volume>30</volume>
<year>2002</year>
<fpage>13</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">11753382</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Analysis of alternative splicing with microarrays: successes and challenges</article-title>
<source/>Genome Biol.
          <volume>5</volume>
<year>2004</year>
<fpage>231</fpage>
<pub-id pub-id-type="pmid">15239822</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Z.X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Genetic variation of pre-mRNA alternative splicing in human populations</article-title>
<source/>Wiley Interdiscip. Rev. RNA
          <volume>3</volume>
<year>2012</year>
<fpage>581</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="pmid">22095823</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>RNA-Seq: a revolutionary tool for transcriptomics</article-title>
<source/>Nat. Rev. Genet.
          <volume>10</volume>
<year>2009</year>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">19015660</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodwin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>McCombie</surname>
<given-names>W.R.</given-names>
</name>
</person-group>
<article-title>Coming of age: ten years of next-generation sequencing technologies</article-title>
<source/>Nat. Rev. Genet.
          <volume>17</volume>
<year>2016</year>
<fpage>333</fpage>
<lpage>351</lpage>
<pub-id pub-id-type="pmid">27184599</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mortazavi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>McCue</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schaeffer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>
<source/>Nat. Methods
          <volume>5</volume>
<year>2008</year>
<fpage>621</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="pmid">18516045</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collado-Torres</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nellore</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kammers</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Taub</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Langmead</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Leek</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Reproducible RNA-seq analysis using recount2</article-title>
<source/>Nat. Biotechnol.
          <volume>35</volume>
<year>2017</year>
<fpage>319</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="pmid">28398307</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byron</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Van Keuren-Jensen</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Engelthaler</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Carpten</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Translating RNA sequencing into clinical diagnostics: opportunities and challenges</article-title>
<source/>Nat. Rev. Genet.
          <volume>17</volume>
<year>2016</year>
<fpage>257</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="pmid">26996076</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duff</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Graveley</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.L.</given-names>
</name>
</person-group>
<article-title>Genomewide characterization of non-polyadenylated RNAs</article-title>
<source/>Genome Biol.
          <volume>12</volume>
<year>2011</year>
<fpage>R16</fpage>
<pub-id pub-id-type="pmid">21324177</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salzman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gawad</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Lacayo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P.O.</given-names>
</name>
</person-group>
<article-title>Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types</article-title>
<source/>PLoS ONE
          <volume>7</volume>
<year>2012</year>
<fpage>e30733</fpage>
<pub-id pub-id-type="pmid">22319583</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilgner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Chakrabortty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Djebali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Curado</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gingeras</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Guigó</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs</article-title>
<source/>Genome Res.
          <volume>22</volume>
<year>2012</year>
<fpage>1616</fpage>
<lpage>1625</lpage>
<pub-id pub-id-type="pmid">22955974</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Cody</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Jog</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Biancolella</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Treacy</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schroth</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Housman</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins</article-title>
<source/>Cell
          <volume>150</volume>
<year>2012</year>
<fpage>710</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="pmid">22901804</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatt</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Pandya-Jones</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Barozzi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lissner</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Natoli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Smale</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions</article-title>
<source/>Cell
          <volume>150</volume>
<year>2012</year>
<fpage>279</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="pmid">22817891</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandberg</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Entering the era of single-cell transcriptomics in biology and medicine</article-title>
<source/>Nat. Methods
          <volume>11</volume>
<year>2014</year>
<fpage>22</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">24524133</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Botvinnik</surname>
<given-names>O.B.</given-names>
</name>
<name>
<surname>Lovci</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Kakaradov</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>G.W.</given-names>
</name>
</person-group>
<article-title>Single-Cell Alternative Splicing Analysis with Expedition Reveals Splicing Dynamics during Neuron Differentiation</article-title>
<source/>Mol. Cell
          <volume>67</volume>
<year>2017</year>
<fpage>148</fpage>
<lpage>161.e5</lpage>
<pub-id pub-id-type="pmid">28673540</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilgner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jahanbani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Blauwkamp</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Moshrefi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jaeger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bustamante</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Comprehensive transcriptome analysis using synthetic long-read sequencing reveals molecular co-association of distant splicing events</article-title>
<source/>Nat. Biotechnol.
          <volume>33</volume>
<year>2015</year>
<fpage>736</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="pmid">25985263</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaisson</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>E.E.</given-names>
</name>
</person-group>
<article-title>Genetic variation and the de novo assembly of human genomes</article-title>
<source/>Nat. Rev. Genet.
          <volume>16</volume>
<year>2015</year>
<fpage>627</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="pmid">26442640</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhoads</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>K.F.</given-names>
</name>
</person-group>
<article-title>PacBio Sequencing and Its Applications</article-title>
<source/>Genomics Proteomics Bioinformatics
          <volume>13</volume>
<year>2015</year>
<fpage>278</fpage>
<lpage>289</lpage>
<pub-id pub-id-type="pmid">26542840</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Nanopore-based fourth-generation DNA sequencing technology</article-title>
<source/>Genomics Proteomics Bioinformatics
          <volume>13</volume>
<year>2015</year>
<fpage>4</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">25743089</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Au</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Sebastiano</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Afshar</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Durruthy</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>van Bakel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schadt</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Reijo-Pera</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Underwood</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>W.H.</given-names>
</name>
</person-group>
<article-title>Characterization of the human ESC transcriptome by hybrid sequencing</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>110</volume>
<year>2013</year>
<fpage>E4821</fpage>
<lpage>E4830</lpage>
<pub-id pub-id-type="pmid">24282307</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tilgner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Grubert</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A single-molecule long-read survey of the human transcriptome</article-title>
<source/>Nat. Biotechnol.
          <volume>31</volume>
<year>2013</year>
<fpage>1009</fpage>
<lpage>1014</lpage>
<pub-id pub-id-type="pmid">24108091</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolisetty</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Rajadinakaran</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Graveley</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Determining exon connectivity in complex mRNAs by nanopore sequencing</article-title>
<source/>Genome Biol.
          <volume>16</volume>
<year>2015</year>
<fpage>204</fpage>
<pub-id pub-id-type="pmid">26420219</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byrne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Beaudin</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>DuBois</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Forsberg</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Akeson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vollmers</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Nanopore long-read RNAseq reveals widespread transcriptional variation among the surface receptors of individual B cells</article-title>
<source/>Nat. Commun.
          <volume>8</volume>
<year>2017</year>
<fpage>16027</fpage>
<pub-id pub-id-type="pmid">28722025</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lubeck</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Coskun</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Zhiyentayev</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Single-cell in situ RNA profiling by sequential hybridization</article-title>
<source/>Nat. Methods
          <volume>11</volume>
<year>2014</year>
<fpage>360</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">24681720</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Boettiger</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Moffitt</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells</article-title>
<source/>Science
          <volume>348</volume>
<year>2015</year>
<fpage>aaa6090</fpage>
<pub-id pub-id-type="pmid">25858977</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alamancos</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Agirre</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Eyras</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Methods to study splicing from high-throughput RNA sequencing data</article-title>
<source/>Methods Mol. Biol.
          <volume>1126</volume>
<year>2014</year>
<fpage>357</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="pmid">24549677</pub-id>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conesa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Madrigal</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tarazona</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gomez-Cabrero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cervera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szcześniak</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Gaffney</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Elo</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mortazavi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A survey of best practices for RNA-seq data analysis</article-title>
<source/>Genome Biol.
          <volume>17</volume>
<year>2016</year>
<fpage>13</fpage>
<pub-id pub-id-type="pmid">26813401</pub-id>
</element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs</article-title>
<source/>Nucleic Acids Res.
          <volume>34</volume>
<year>2006</year>
<fpage>3150</fpage>
<lpage>3160</lpage>
<pub-id pub-id-type="pmid">16757580</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trapnell</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Pertea</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mortazavi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>van Baren</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Pachter</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>
<source/>Nat. Biotechnol.
          <volume>28</volume>
<year>2010</year>
<fpage>511</fpage>
<lpage>515</lpage>
<pub-id pub-id-type="pmid">20436464</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bray</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Melsted</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pachter</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Near-optimal probabilistic RNA-seq quantification</article-title>
<source/>Nat. Biotechnol.
          <volume>34</volume>
<year>2016</year>
<fpage>525</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="pmid">27043002</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Duggal</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Irizarry</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Kingsford</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title>
<source/>Nat. Methods
          <volume>14</volume>
<year>2017</year>
<fpage>417</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="pmid">28263959</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Airoldi</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Analysis and design of RNA sequencing experiments for identifying isoform regulation</article-title>
<source/>Nat. Methods
          <volume>7</volume>
<year>2010</year>
<fpage>1009</fpage>
<lpage>1015</lpage>
<pub-id pub-id-type="pmid">21057496</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>111</volume>
<year>2014</year>
<fpage>E5593</fpage>
<lpage>E5601</lpage>
<pub-id pub-id-type="pmid">25480548</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Akerman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McCombie</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Krainer</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.Q.</given-names>
</name>
</person-group>
<article-title>SpliceTrap: a method to quantify alternative splicing under single cellular conditions</article-title>
<source/>Bioinformatics
          <volume>27</volume>
<year>2011</year>
<fpage>3010</fpage>
<lpage>3016</lpage>
<pub-id pub-id-type="pmid">21896509</pub-id>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alamancos</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Pagès</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trincado</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Bellora</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Eyras</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Leveraging transcript quantification for fast computation of alternative splicing profiles</article-title>
<source/>RNA
          <volume>21</volume>
<year>2015</year>
<fpage>1521</fpage>
<lpage>1531</lpage>
<pub-id pub-id-type="pmid">26179515</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>SURVIV for survival analysis of mRNA isoform variation</article-title>
<source/>Nat. Commun.
          <volume>7</volume>
<year>2016</year>
<fpage>11548</fpage>
<pub-id pub-id-type="pmid">27279334</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Tukiainen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Donkervoort</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Bolduc</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Waddell</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Sandaradura</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>O’Grady</surname>
<given-names>G.L.</given-names>
</name>
<collab>Genotype-Tissue Expression Consortium</collab>
</person-group>
<article-title>Improving genetic diagnosis in Mendelian disease with transcriptome sequencing</article-title>
<source/>Sci. Transl. Med.
          <volume>9</volume>
<year>2017</year>
<fpage>eaal5209</fpage>
<pub-id pub-id-type="pmid">28424332</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.X.</given-names>
</name>
<name>
<surname>Bahrami-Samani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Discover hidden splicing variations by mapping personal transcriptomes to personal genomes</article-title>
<source/>Nucleic Acids Res.
          <volume>43</volume>
<year>2015</year>
<fpage>10612</fpage>
<lpage>10622</lpage>
<pub-id pub-id-type="pmid">26578562</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.X.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data</article-title>
<source/>Genome Biol.
          <volume>14</volume>
<year>2013</year>
<fpage>R74</fpage>
<pub-id pub-id-type="pmid">23876401</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ongen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dermitzakis</surname>
<given-names>E.T.</given-names>
</name>
</person-group>
<article-title>Alternative Splicing QTLs in European and African Populations</article-title>
<source/>Am. J. Hum. Genet.
          <volume>97</volume>
<year>2015</year>
<fpage>567</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">26430802</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monlong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calvo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Guigó</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Identification of genetic variants associated with alternative splicing using sQTLseekeR</article-title>
<source/>Nat. Commun.
          <volume>5</volume>
<year>2014</year>
<fpage>4698</fpage>
<pub-id pub-id-type="pmid">25140736</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mapping Splicing Quantitative Trait Loci in RNA-Seq</article-title>
<source/>Cancer Inform.
          <volume>14</volume>
<issue>Suppl 1</issue>
<year>2015</year>
<fpage>45</fpage>
<lpage>53</lpage>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>ulfasQTL: an ultra-fast method of composite splicing QTL analysis</article-title>
<source/>BMC Genomics
          <volume>18</volume>
<issue>Suppl 1</issue>
<year>2017</year>
<fpage>963</fpage>
<pub-id pub-id-type="pmid">28198669</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battle</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mostafavi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Potash</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>McCormick</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Haudenschild</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Beckman</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals</article-title>
<source/>Genome Res.
          <volume>24</volume>
<year>2014</year>
<fpage>14</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">24092820</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bahn</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Identification of allele-specific alternative mRNA processing via transcriptome sequencing</article-title>
<source/>Nucleic Acids Res.
          <volume>40</volume>
<year>2012</year>
<fpage>e104</fpage>
<pub-id pub-id-type="pmid">22467206</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lappalainen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sammeth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Friedländer</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>’t Hoen</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Monlong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rivas</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Gonzàlez-Porta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kurbatova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Griebel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>P.G.</given-names>
</name>
<collab>Geuvadis Consortium</collab>
</person-group>
<article-title>Transcriptome and genome sequencing uncovers functional variation in humans</article-title>
<source/>Nature
          <volume>501</volume>
<year>2013</year>
<fpage>506</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="pmid">24037378</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Demirdjian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Population and allelic variation of A-to-I RNA editing in human transcriptomes</article-title>
<source/>Genome Biol.
          <volume>18</volume>
<year>2017</year>
<fpage>143</fpage>
<pub-id pub-id-type="pmid">28754146</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilgner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Grubert</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sharon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Defining a personal, allele-specific, and single-molecule long-read transcriptome</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>111</volume>
<year>2014</year>
<fpage>9869</fpage>
<lpage>9874</lpage>
<pub-id pub-id-type="pmid">24961374</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Bahn</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Alternative splicing modulated by genetic variants demonstrates accelerated evolution regulated by highly conserved proteins</article-title>
<source/>Genome Res.
          <volume>26</volume>
<year>2016</year>
<fpage>440</fpage>
<lpage>450</lpage>
<pub-id pub-id-type="pmid">26888265</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montgomery</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Sammeth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gutierrez-Arcelus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lach</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Ingle</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nisbett</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guigo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dermitzakis</surname>
<given-names>E.T.</given-names>
</name>
</person-group>
<article-title>Transcriptome genetics using second generation sequencing in a Caucasian population</article-title>
<source/>Nature
          <volume>464</volume>
<year>2010</year>
<fpage>773</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="pmid">20220756</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickrell</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Pai</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Degner</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Nkadori</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Veyrieras</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pritchard</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Understanding mechanisms underlying human gene expression variation with RNA sequencing</article-title>
<source/>Nature
          <volume>464</volume>
<year>2010</year>
<fpage>768</fpage>
<lpage>772</lpage>
<pub-id pub-id-type="pmid">20220758</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fadista</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vikman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Laakso</surname>
<given-names>E.O.</given-names>
</name>
<name>
<surname>Mollet</surname>
<given-names>I.G.</given-names>
</name>
<name>
<surname>Esguerra</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Taneera</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Storm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Osmark</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ladenvall</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>111</volume>
<year>2014</year>
<fpage>13924</fpage>
<lpage>13929</lpage>
<pub-id pub-id-type="pmid">25201977</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Battle</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Zappala</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Kukurba</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Transcriptome sequencing of a large human family identifies the impact of rare noncoding variants</article-title>
<source/>Am. J. Hum. Genet.
          <volume>95</volume>
<year>2014</year>
<fpage>245</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="pmid">25192044</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<collab>GTEx Consortium</collab>
</person-group>
<article-title>Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>
<source/>Science
          <volume>348</volume>
<year>2015</year>
<fpage>648</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="pmid">25954001</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Casale</surname>
<given-names>F.P.</given-names>
</name>
<name>
<surname>Vasquez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Garrido-Martín</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ecker</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells</article-title>
<source/>Cell
          <volume>167</volume>
<year>2016</year>
<fpage>1398</fpage>
<lpage>1414.e24</lpage>
<pub-id pub-id-type="pmid">27863251</pub-id>
</element-citation>
</ref>
<ref id="bib74">
<label>74</label>
<element-citation id="sref74" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pala</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zappala</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Marongiu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Cusano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Crobu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kukurba</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Gloudemans</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Reinier</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Population- and individual-specific regulatory variation in Sardinia</article-title>
<source/>Nat. Genet.
          <volume>49</volume>
<year>2017</year>
<fpage>700</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="pmid">28394350</pub-id>
</element-citation>
</ref>
<ref id="bib75">
<label>75</label>
<element-citation id="sref75" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci</article-title>
<source/>Nat. Commun.
          <volume>8</volume>
<year>2017</year>
<fpage>14519</fpage>
<pub-id pub-id-type="pmid">28240266</pub-id>
</element-citation>
</ref>
<ref id="bib76">
<label>76</label>
<element-citation id="sref76" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lalonde</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bemmo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kleinman</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pastinen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Majewski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression</article-title>
<source/>Genome Res.
          <volume>21</volume>
<year>2011</year>
<fpage>545</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="pmid">21173033</pub-id>
</element-citation>
</ref>
<ref id="bib77">
<label>77</label>
<element-citation id="sref77" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neitzel</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>A routine method for the establishment of permanent growing lymphoblastoid cell lines</article-title>
<source/>Hum. Genet.
          <volume>73</volume>
<year>1986</year>
<fpage>320</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="pmid">3017841</pub-id>
</element-citation>
</ref>
<ref id="bib78">
<label>78</label>
<element-citation id="sref78" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altshuler</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Peltonen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Peltonen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dermitzakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schaffner</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Peltonen</surname>
<given-names>L.</given-names>
</name>
<collab>International HapMap 3 Consortium</collab>
</person-group>
<article-title>Integrating common and rare genetic variation in diverse human populations</article-title>
<source/>Nature
          <volume>467</volume>
<year>2010</year>
<fpage>52</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">20811451</pub-id>
</element-citation>
</ref>
<ref id="bib79">
<label>79</label>
<element-citation id="sref79" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Garrison</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Korbel</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Marchini</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McVean</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>G.R.</given-names>
</name>
<collab>1000 Genomes Project Consortium</collab>
</person-group>
<article-title>A global reference for human genetic variation</article-title>
<source/>Nature
          <volume>526</volume>
<year>2015</year>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">26432245</pub-id>
</element-citation>
</ref>
<ref id="bib80">
<label>80</label>
<element-citation id="sref80" publication-type="journal">
<person-group person-group-type="author">
<collab>GTEx Consortium</collab>
</person-group>
<article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
<source/>Nat. Genet.
          <volume>45</volume>
<year>2013</year>
<fpage>580</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="pmid">23715323</pub-id>
</element-citation>
</ref>
<ref id="bib81">
<label>81</label>
<element-citation id="sref81" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Human genomics: Cracking the regulatory code</article-title>
<source/>Nature
          <volume>550</volume>
<year>2017</year>
<fpage>190</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">29022577</pub-id>
</element-citation>
</ref>
<ref id="bib82">
<label>82</label>
<element-citation id="sref82" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Jaquish</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>The NextGen Genetic Association Studies Consortium: A Foray into In Vitro Population Genetics</article-title>
<source/>Cell Stem Cell
          <volume>20</volume>
<year>2017</year>
<fpage>431</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="pmid">28388427</pub-id>
</element-citation>
</ref>
<ref id="bib83">
<label>83</label>
<element-citation id="sref83" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Joehanes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Huan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Munson</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>O’Donnell</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Identification of common genetic variants controlling transcript isoform variation in human whole blood</article-title>
<source/>Nat. Genet.
          <volume>47</volume>
<year>2015</year>
<fpage>345</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">25685889</pub-id>
</element-citation>
</ref>
<ref id="bib84">
<label>84</label>
<element-citation id="sref84" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.I.</given-names>
</name>
<name>
<surname>van de Geijn</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Petti</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Golan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pritchard</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>RNA splicing is a primary link between genetic variation and disease</article-title>
<source/>Science
          <volume>352</volume>
<year>2016</year>
<fpage>600</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="pmid">27126046</pub-id>
</element-citation>
</ref>
<ref id="bib85">
<label>85</label>
<element-citation id="sref85" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>de la Monte</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Guigaouri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Filippov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>K.D.</given-names>
</name>
</person-group>
<article-title>Identification and characterization of a leukocyte-specific component of the nuclear body</article-title>
<source/>J. Biol. Chem.
          <volume>271</volume>
<year>1996</year>
<fpage>29198</fpage>
<lpage>29204</lpage>
<pub-id pub-id-type="pmid">8910577</pub-id>
</element-citation>
</ref>
<ref id="bib86">
<label>86</label>
<element-citation id="sref86" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zucchelli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tamburri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Quilici</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Palagano</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Berardi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saare</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bachi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Musco</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Structure of human Sp140 PHD finger: an atypical fold interacting with Pin1</article-title>
<source/>FEBS J.
          <volume>281</volume>
<year>2014</year>
<fpage>216</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">24267382</pub-id>
</element-citation>
</ref>
<ref id="bib87">
<label>87</label>
<element-citation id="sref87" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Bernardo</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Crowther-Swanepoel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Broderick</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sellick</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wild</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vijayakrishnan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pittman</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia</article-title>
<source/>Nat. Genet.
          <volume>40</volume>
<year>2008</year>
<fpage>1204</fpage>
<lpage>1210</lpage>
<pub-id pub-id-type="pmid">18758461</pub-id>
</element-citation>
</ref>
<ref id="bib88">
<label>88</label>
<element-citation id="sref88" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawcer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hellenthal</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pirinen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Patsopoulos</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Moutsianas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dilthey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>S.E.</given-names>
</name>
<collab>International Multiple Sclerosis Genetics Consortium</collab>
<collab>Wellcome Trust Case Control Consortium 2</collab>
</person-group>
<article-title>Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis</article-title>
<source/>Nature
          <volume>476</volume>
<year>2011</year>
<fpage>214</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="pmid">21833088</pub-id>
</element-citation>
</ref>
<ref id="bib89">
<label>89</label>
<element-citation id="sref89" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McGovern</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Radford-Smith</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Balschun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci</article-title>
<source/>Nat. Genet.
          <volume>42</volume>
<year>2010</year>
<fpage>1118</fpage>
<lpage>1125</lpage>
<pub-id pub-id-type="pmid">21102463</pub-id>
</element-citation>
</ref>
<ref id="bib90">
<label>90</label>
<element-citation id="sref90" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.Z.</given-names>
</name>
<name>
<surname>van Sommeren</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Alberts</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ripke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Jostins</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>T.</given-names>
</name>
<collab>International Multiple Sclerosis Genetics Consortium</collab>
<collab>International IBD Genetics Consortium</collab>
</person-group>
<article-title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations</article-title>
<source/>Nat. Genet.
          <volume>47</volume>
<year>2015</year>
<fpage>979</fpage>
<lpage>986</lpage>
<pub-id pub-id-type="pmid">26192919</pub-id>
</element-citation>
</ref>
<ref id="bib91">
<label>91</label>
<element-citation id="sref91" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title>
<source/>Bioinformatics
          <volume>21</volume>
<year>2005</year>
<fpage>263</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="pmid">15297300</pub-id>
</element-citation>
</ref>
<ref id="bib92">
<label>92</label>
<element-citation id="sref92" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matesanz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Potenciano</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fedetz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramos-Mozo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Abad-Grau</surname>
<given-names>Mdel.M.</given-names>
</name>
<name>
<surname>Karaky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barrionuevo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Izquierdo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ruiz-Peña</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>García-Sánchez</surname>
<given-names>M.I.</given-names>
</name>
</person-group>
<article-title>A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis</article-title>
<source/>Hum. Mol. Genet.
          <volume>24</volume>
<year>2015</year>
<fpage>5619</fpage>
<lpage>5627</lpage>
<pub-id pub-id-type="pmid">26152201</pub-id>
</element-citation>
</ref>
<ref id="bib93">
<label>93</label>
<element-citation id="sref93" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coulombe-Huntington</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Majewski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Fine-scale variation and genetic determinants of alternative splicing across individuals</article-title>
<source/>PLoS Genet.
          <volume>5</volume>
<year>2009</year>
<fpage>e1000766</fpage>
<pub-id pub-id-type="pmid">20011102</pub-id>
</element-citation>
</ref>
<ref id="bib94">
<label>94</label>
<element-citation id="sref94" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrés</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Cannons</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Lee-Lin</surname>
<given-names>S.Q.</given-names>
</name>
<name>
<surname>Hurle</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schwartzberg</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Bustamante</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>R.</given-names>
</name>
<collab>NISC Comparative Sequencing Program</collab>
</person-group>
<article-title>Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation</article-title>
<source/>PLoS Genet.
          <volume>6</volume>
<year>2010</year>
<fpage>e1001157</fpage>
<pub-id pub-id-type="pmid">20976248</pub-id>
</element-citation>
</ref>
<ref id="bib95">
<label>95</label>
<element-citation id="sref95" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanioka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsujimoto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases</article-title>
<source/>J. Biol. Chem.
          <volume>278</volume>
<year>2003</year>
<fpage>32275</fpage>
<lpage>32283</lpage>
<pub-id pub-id-type="pmid">12799365</pub-id>
</element-citation>
</ref>
<ref id="bib96">
<label>96</label>
<element-citation id="sref96" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eilbeck</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yandell</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Settling the score: variant prioritization and Mendelian disease</article-title>
<source/>Nat. Rev. Genet.
          <volume>18</volume>
<year>2017</year>
<fpage>599</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="pmid">28804138</pub-id>
</element-citation>
</ref>
<ref id="bib97">
<label>97</label>
<element-citation id="sref97" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing</article-title>
<source/>Biotechniques
          <volume>41</volume>
<year>2006</year>
<fpage>177</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="pmid">16925019</pub-id>
</element-citation>
</ref>
<ref id="bib98">
<label>98</label>
<element-citation id="sref98" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starita</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Ahituv</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dunham</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kitzman</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>F.P.</given-names>
</name>
<name>
<surname>Seelig</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Variant Interpretation: Functional Assays to the Rescue</article-title>
<source/>Am. J. Hum. Genet.
          <volume>101</volume>
<year>2017</year>
<fpage>315</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">28886340</pub-id>
</element-citation>
</ref>
<ref id="bib99">
<label>99</label>
<element-citation id="sref99" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenberg</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Patwardhan</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seelig</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Learning the sequence determinants of alternative splicing from millions of random sequences</article-title>
<source/>Cell
          <volume>163</volume>
<year>2015</year>
<fpage>698</fpage>
<lpage>711</lpage>
<pub-id pub-id-type="pmid">26496609</pub-id>
</element-citation>
</ref>
<ref id="bib100">
<label>100</label>
<element-citation id="sref100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soemedi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cygan</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Rhine</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bulacan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bayrak-Toydemir</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fairbrother</surname>
<given-names>W.G.</given-names>
</name>
</person-group>
<article-title>Pathogenic variants that alter protein code often disrupt splicing</article-title>
<source/>Nat. Genet.
          <volume>49</volume>
<year>2017</year>
<fpage>848</fpage>
<lpage>855</lpage>
<pub-id pub-id-type="pmid">28416821</pub-id>
</element-citation>
</ref>
<ref id="bib101">
<label>101</label>
<element-citation id="sref101" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Stoilov</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Chromatin and epigenetic regulation of pre-mRNA processing</article-title>
<source/>Hum. Mol. Genet.
          <volume>21</volume>
<issue>R1</issue>
<year>2012</year>
<fpage>R90</fpage>
<lpage>R96</lpage>
<pub-id pub-id-type="pmid">22936691</pub-id>
</element-citation>
</ref>
<ref id="bib102">
<label>102</label>
<element-citation id="sref102" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linares</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Damianov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Novitch</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation</article-title>
<source/>eLife
          <volume>4</volume>
<year>2015</year>
<fpage>e09268</fpage>
<pub-id pub-id-type="pmid">26705333</pub-id>
</element-citation>
</ref>
<ref id="bib103">
<label>103</label>
<element-citation id="sref103" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libbrecht</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Machine learning applications in genetics and genomics</article-title>
<source/>Nat. Rev. Genet.
          <volume>16</volume>
<year>2015</year>
<fpage>321</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="pmid">25948244</pub-id>
</element-citation>
</ref>
<ref id="bib104">
<label>104</label>
<element-citation id="sref104" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorek</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shemesh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Basechess</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ast</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shamir</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A non-EST-based method for exon-skipping prediction</article-title>
<source/>Genome Res.
          <volume>14</volume>
<year>2004</year>
<fpage>1617</fpage>
<lpage>1623</lpage>
<pub-id pub-id-type="pmid">15289480</pub-id>
</element-citation>
</ref>
<ref id="bib105">
<label>105</label>
<element-citation id="sref105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dror</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sorek</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shamir</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Accurate identification of alternatively spliced exons using support vector machine</article-title>
<source/>Bioinformatics
          <volume>21</volume>
<year>2005</year>
<fpage>897</fpage>
<lpage>901</lpage>
<pub-id pub-id-type="pmid">15531599</pub-id>
</element-citation>
</ref>
<ref id="bib106">
<label>106</label>
<element-citation id="sref106" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rätsch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sonnenburg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schölkopf</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>RASE: recognition of alternatively spliced exons in C.elegans</article-title>
<source/>Bioinformatics
          <volume>21</volume>
<issue>Suppl 1</issue>
<year>2005</year>
<fpage>i369</fpage>
<lpage>i377</lpage>
<pub-id pub-id-type="pmid">15961480</pub-id>
</element-citation>
</ref>
<ref id="bib107">
<label>107</label>
<element-citation id="sref107" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeo</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Van Nostrand</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Holste</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Poggio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Identification and analysis of alternative splicing events conserved in human and mouse</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>102</volume>
<year>2005</year>
<fpage>2850</fpage>
<lpage>2855</lpage>
<pub-id pub-id-type="pmid">15708978</pub-id>
</element-citation>
</ref>
<ref id="bib108">
<label>108</label>
<element-citation id="sref108" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barash</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Calarco</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shai</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Deciphering the splicing code</article-title>
<source/>Nature
          <volume>465</volume>
<year>2010</year>
<fpage>53</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="pmid">20445623</pub-id>
</element-citation>
</ref>
<ref id="bib109">
<label>109</label>
<element-citation id="sref109" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Barash</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Bayesian prediction of tissue-regulated splicing using RNA sequence and cellular context</article-title>
<source/>Bioinformatics
          <volume>27</volume>
<year>2011</year>
<fpage>2554</fpage>
<lpage>2562</lpage>
<pub-id pub-id-type="pmid">21803804</pub-id>
</element-citation>
</ref>
<ref id="bib110">
<label>110</label>
<element-citation id="sref110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barash</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vaquero-Garcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>González-Vallinas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>AVISPA: a web tool for the prediction and analysis of alternative splicing</article-title>
<source/>Genome Biol.
          <volume>14</volume>
<year>2013</year>
<fpage>R114</fpage>
<pub-id pub-id-type="pmid">24156756</pub-id>
</element-citation>
</ref>
<ref id="bib111">
<label>111</label>
<element-citation id="sref111" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Deep learning of the tissue-regulated splicing code</article-title>
<source/>Bioinformatics
          <volume>30</volume>
<year>2014</year>
<fpage>i121</fpage>
<lpage>i129</lpage>
<pub-id pub-id-type="pmid">24931975</pub-id>
</element-citation>
</ref>
<ref id="bib112">
<label>112</label>
<element-citation id="sref112" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Alipanahi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Bretschneider</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gueroussov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Najafabadi</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>T.R.</given-names>
</name>
</person-group>
<article-title>RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease</article-title>
<source/>Science
          <volume>347</volume>
<year>2015</year>
<fpage>1254806</fpage>
<pub-id pub-id-type="pmid">25525159</pub-id>
</element-citation>
</ref>
<ref id="bib113">
<label>113</label>
<element-citation id="sref113" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jha</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gazzara</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Barash</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Integrative deep models for alternative splicing</article-title>
<source/>Bioinformatics
          <volume>33</volume>
<year>2017</year>
<fpage>i274</fpage>
<lpage>i282</lpage>
<pub-id pub-id-type="pmid">28882000</pub-id>
</element-citation>
</ref>
<ref id="bib114">
<label>114</label>
<element-citation id="sref114" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeCun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bengio</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hinton</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Deep learning</article-title>
<source/>Nature
          <volume>521</volume>
<year>2015</year>
<fpage>436</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="pmid">26017442</pub-id>
</element-citation>
</ref>
<ref id="bib115">
<label>115</label>
<element-citation id="sref115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angermueller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pärnamaa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Parts</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stegle</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Deep learning for computational biology</article-title>
<source/>Mol. Syst. Biol.
          <volume>12</volume>
<year>2016</year>
<fpage>878</fpage>
<pub-id pub-id-type="pmid">27474269</pub-id>
</element-citation>
</ref>
<ref id="bib116">
<label>116</label>
<element-citation id="sref116" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sanguinetti</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>BRIE: transcriptome-wide splicing quantification in single cells</article-title>
<source/>Genome Biol.
          <volume>18</volume>
<year>2017</year>
<fpage>123</fpage>
<pub-id pub-id-type="pmid">28655331</pub-id>
</element-citation>
</ref>
<ref id="bib117">
<label>117</label>
<mixed-citation id="sref117" publication-type="other">Van Nostrand, E.L., Freese, P., Pratt, G.A., Wang, X., Wei, X., Blue, S.M., Dominguez, D., Cody, N.A.L., Olson, S., Sundararaman, B., et al. (2017). A Large-Scale Binding and Functional Map of Human RNA Binding Proteins. bioRxiv doi: <ext-link ext-link-type="uri" id="intref0015" xlink:href="https://doi.org/10.1101/179648">https://doi.org/10.1101/179648</ext-link>.</mixed-citation>
</ref>
<ref id="bib118">
<label>118</label>
<element-citation id="sref118" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Ferraris</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Filloux</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Raphael</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Fairbrother</surname>
<given-names>W.G.</given-names>
</name>
</person-group>
<article-title>Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <volume>108</volume>
<year>2011</year>
<fpage>11093</fpage>
<lpage>11098</lpage>
<pub-id pub-id-type="pmid">21685335</pub-id>
</element-citation>
</ref>
<ref id="bib119">
<label>119</label>
<element-citation id="sref119" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolfe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mullikin</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Elnitski</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Genomic features defining exonic variants that modulate splicing</article-title>
<source/>Genome Biol.
          <volume>11</volume>
<year>2010</year>
<fpage>R20</fpage>
<pub-id pub-id-type="pmid">20158892</pub-id>
</element-citation>
</ref>
<ref id="bib120">
<label>120</label>
<element-citation id="sref120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mort</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sterne-Weiler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Radivojac</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sanford</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Mooney</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing</article-title>
<source/>Genome Biol.
          <volume>15</volume>
<year>2014</year>
<fpage>R19</fpage>
<pub-id pub-id-type="pmid">24451234</pub-id>
</element-citation>
</ref>
<ref id="bib121">
<label>121</label>
<element-citation id="sref121" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mort</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>ExonImpact: Prioritizing Pathogenic Alternative Splicing Events</article-title>
<source/>Hum. Mutat.
          <volume>38</volume>
<year>2017</year>
<fpage>16</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">27604408</pub-id>
</element-citation>
</ref>
<ref id="bib122">
<label>122</label>
<element-citation id="sref122" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corey</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy</article-title>
<source/>Nat. Neurosci.
          <volume>20</volume>
<year>2017</year>
<fpage>497</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="pmid">28192393</pub-id>
</element-citation>
</ref>
<ref id="bib123">
<label>123</label>
<element-citation id="sref123" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trincado</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Sebestyén</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pagés</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eyras</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The prognostic potential of alternative transcript isoforms across human tumors</article-title>
<source/>Genome Med.
          <volume>8</volume>
<year>2016</year>
<fpage>85</fpage>
<pub-id pub-id-type="pmid">27535130</pub-id>
</element-citation>
</ref>
<ref id="bib124">
<label>124</label>
<mixed-citation id="sref124" publication-type="other">Johnson, N.T., Dhroso, A., Hughes, K.J., and Korkin, D. (2017). Biological classification with RNA-Seq data: Can alternative splicing enhance machine learning classifier? bioRxiv, <ext-link ext-link-type="uri" id="intref0020" xlink:href="https://doi.org/10.1101/146340">https://doi.org/10.1101/146340</ext-link>.</mixed-citation>
</ref>
<ref id="bib125">
<label>125</label>
<element-citation id="sref125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gymrek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Guilmatre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Markus</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Georgiev</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Pritchard</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Erlich</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Abundant contribution of short tandem repeats to gene expression variation in humans</article-title>
<source/>Nat. Genet.
          <volume>48</volume>
<year>2016</year>
<fpage>22</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">26642241</pub-id>
</element-citation>
</ref>
<ref id="bib126">
<label>126</label>
<element-citation id="sref126" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mort</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation</article-title>
<source/>Hum. Mol. Genet.
          <volume>23</volume>
<year>2014</year>
<fpage>3024</fpage>
<lpage>3034</lpage>
<pub-id pub-id-type="pmid">24436305</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="app1">
<title>Web Resources</title>
<p id="p0170">
<list list-type="simple">
<list-item id="u0010">
<p id="p0175">rmats2sashimiplot, <ext-link ext-link-type="uri" id="intref0010" xlink:href="https://github.com/Xinglab/rmats2sashimiplot">https://github.com/Xinglab/rmats2sashimiplot</ext-link></p>
</list-item>
</list>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgments</title>
<p>We thank Maggie Lam, John Phillips, Douglas Black, Andrey Damianov, Yang Pan, Levon Demirdjian, and Rocky Cheung for their helpful comments and Shihao Shen for technical assistance. This work was supported by <funding-source id="gs1">National Institutes of Health</funding-source> grants R01GM088342 and R01GM117624 to Y.X. Y.X. is supported by an <funding-source id="gs2">Alfred Sloan Research Fellowship</funding-source> (BR2013-117). E.P. is supported by <funding-source id="gs3">National Institutes of Health</funding-source> postdoctoral training grant T32AR059033. Y.X. is a scientific cofounder of Trimontia Genomics Inc. and IsoTex Biotechnology Inc.</p>
</ack>
</back>
</article>
</pmc-articleset>